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Abstract 
In cells, cytoplasmic dynein is important for cell division and retrograde transport of 
organelles and macromolecules. Although a microtubule minus end directed motor, 
dynein often localises to the plus ends of microtubules. The growing microtubule plus 
ends are thought to serve as important sites of cargo loading and initiation of dynein 
driven transport. During mitosis, dynein interacts with the plus ends of cortical and 
kinetochore microtubules where its activity appears essential for spindle positioning, 
chromosome alignment and checkpoint protein removal. In cells, to track plus ends, 
dynein interacts with its key regulators—dynactin and Lis1—which, together with the 
cargo adaptor BicD2, are also involved in dynein driven motion away from the plus 
ends. How do these dynein regulators control the plus end localisation versus minus end 
motion of dynein on dynamic microtubules? To address this, I study the regulation of 
the recombinant human dynein by dynactin, Lis1 and BicD2 on dynamic microtubules 
in the presence of the end binding protein EB1 using an in vitro reconstitution approach 
combined with TIRF microscopy. This allows simultaneous investigation of dynein 
motility and microtubule end tracking in the same assay and sheds light on the 
mechanism of dynein regulation for the two dynein processes. 
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Chapter 1. Introduction 
1.1 Microtubule cytoskeleton 
The microtubules cytoskeleton forms the framework of eukaryotic cells and is involved 
in many cellular functions (Wade, 2009). The microtubule arrangement generates the 
scaffold for cilia and flagella that are crucial for cell motility. During cell division, the 
microtubule filaments organise into spindles arrays to guide the step-wise process of 
chromosome separation. Another important role of microtubules is to serve as tracks for 
intracellular transport. This latter role is central to this thesis. 
The microtubule filaments are composed of alpha (α) and beta (β) tubulin subunits. The 
α-β tubulin dimers align with the α tubulin of one dimer interacting with the β subunit 
of the adjacent dimer, to generate a protofilament (Figure 1.1) (Amos and Klug, 1974). 
Approximately 13 such protofilaments arrange (Nogales et al., 1999)  to form hollow 
cylinders known as microtubules (Figure 1.1). Assembly from tubulin heterodimers 
leads to the polarisation of the two ends of the microtubule filaments, the α-tubulin 
forming the minus end and the β-tubulin forming the plus end (Desai and Mitchison, 
1997).  These polarized microtubules are dynamic and can switch between growth and 
shrinkage phases in a nucleotide dependent fashion—a property known as dynamic 
instability (Figure 1.2) (Mitchison and Kirschner, 1984). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Microtubule structure  
α-β tubulin dimer polymerises into polarised protofilaments. Approximately 13 protofilaments form the 
cylindrical microtubule. Adapted from (Akhmanova and Steinmetz, 2008) 
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In cells, microtubule filaments constantly grow and shrink in response to the 
environmental stimuli. This allows microtubules to sense the environment and produce 
force for processes such as cell division, cell shape change and cell migration (Desai 
and Mitchison, 1997; Volkov et al., 2013). Blocking the dynamic nature of 
microtubules through drugs such as nocodazole severely inhibits cell division, 
highlighting the crucial role of dynamic instability in cell division (Jordan et al., 1992; 
Vasquez et al., 1997).  
  
 
 
Figure 1.2 Dynamic instability of microtubule  
Microtubules alternate between growing and shrinking phases. In the growth phase the microtubule end is 
protected by a stable GTP cap and shrinking phases in which the GTP cap is lost. The shift from a 
growing to a shrinking phase is referred to as ‘catastrophe’ and the reverse is referred to as ‘rescue’. The 
plus end (indicated as ‘+’ in the figure) is more dynamic than the minus end of a microtubule. Adapted 
from (Akhmanova and Steinmetz, 2008) 
 
 
Microtubule plus ends are more dynamic than the minus ends. The growing plus end 
contains GTP bound β-tubulin (referred to as GTP cap) while the rest of the 
polymerised microtubule lattice remains in GDP-bound state (Amos, 2011; Stewart et 
al., 1990) (Figure 1.2). The hydrolysis of GTP tubulin i.e. loss of GTP cap at the plus 
ends leads to rapid depolymerisation of microtubules termed as ‘catastrophe’; while the 
transition from depolymerisation to growth phase is termed as ‘rescue’ possibly due to 
+ 
+ 
 
Chapter 1 Introduction 
 15 
regaining of the GTP cap at the plus ends (Mitchison and Kirschner, 1984; O'Brien et 
al., 1987).  
A group of proteins accumulate at growing microtubule plus ends and regulate the 
microtubule dynamics, microtubule organisation, and connection to other cellular 
structures such as ER, actin cytoskeleton and cell cortex (Akhmanova and Steinmetz, 
2008). These proteins are known as plus end binding proteins or +TIPs. These +TIPs 
are classified into: (1) autonomous plus end tracking proteins, such as chTOG and end 
binding proteins or EBs that bind to the plus end of the microtubule directly; and (2) EB 
dependent plus end trackers that are recruited to the plus ends by EBs (Akhmanova and 
Steinmetz, 2008).  
 
 
 
 
 
 
Figure 1.3.  Schematic of EB protein 
EBs are dimeric and each monomer has a CH domain (light green) at the N-terminal, and the EB 
homology (EBH) domain (dark green) that terminates in an acid EEY/F tail is present at the C-terminal. 
The CAP-Gly containing +TIPs bind to the EEY/F tail and the SxIP conating +TIPs bind to the EBH 
domain. Picture adapted from (Duellberg et al., 2013) 
 
EBs (EB1, EB2 and EB3 in mammalian cells) interact specifically with the growing 
plus ends of microtubules and not the depolymerizing ends in vitro (Maurer et al., 2012) 
and in vivo (Tirnauer et al., 2002). The EB protein has an N-terminal Calponin 
Homology domain (CH-domain) responsible for a nucleotide-dependent interaction 
with the microtubule end; and a C terminal EB homology domain (EBH) terminating 
with an acidic EEY/F tail (Duellberg et al., 2013) (Figure 1.3). While the CAP-Gly 
domain containing +TIPs (e.g. CLIP170 and p150glued a subunit of dynactin) bind to the 
EEY/F tail of EB, SxIP motif containing +TIPs bind to the EBH domain (Figure 1.3) 
(Akhmanova and Steinmetz, 2008). The binding of the SxIP and CAP-Gly containing 
+TIPs appear to be competitive (Duellberg et al., 2014), possibly because of allosteric 
modulation of the tail region induced by the binding of SxIP proteins (Honnappa et al., 
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2009; Honnappa et al., 2005).  The +TIPs can further recruit several more proteins to 
the plus ends of the microtubule (Figure 1.4), for example, p150glued (the largest subunit 
of the dynactin complex) is involved in plus end localisation of the dynein complex 
(discussed later in this chapter).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 The +TIP network 
A simplified representation of the +TIP network showing autonomus plus end tracking protein EBs that 
can directly interact with the growing plus ends of the microtubules and recruit other plus +TIPs such as, 
CAP-Gly containing CLIP170 and p150 and SxIP motif containing proteins to the microtubule plus ends. 
The EB dependent +TIPs can further recruit other proteins such as dynein motor and Lis1 to the plus 
ends. 
 
Microtubule based molecular motors 
Molecular motors are nanoscale enzymes that are fuelled by ATP and best known as 
transporter of cargos—organelles and macromolecules in cells (Vale, 2003). These 
enzymes hydrolyse ATP and undergo a series of conformational changes that results in 
their stepping/movement on the microtubule filaments. Based on the direction of 
stepping on polarized microtubule filaments, the microtubule-based motors are 
classified as plus end and minus end directed motors. The plus end directed motors 
mainly belong to the kinesin family, and the minus end directed motors are from the 
dynein family (Vale, 2003). Both families of motors have functionally similar domains: 
a motor domain that is the site of ATP hydrolysis and microtubule binding, and a tail 
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domain where the motor dimerises, interacts with accessory proteins, and binds to 
cargos (Vale, 2003) (Figure 1.4). However, the kinesin and dynein motors do not share 
sequence homology or structural similarities.  
 
 
 
 
Figure 1.4 Molecular Motor proteins 
Schematic representation of kinesin-1 (left) and cytoplasmic dynein (right). The motor domains that 
bind to microtubules and hydrolyse ATP are shown in blue and the accessory subunits that bind to 
the tail domain are shown in green. Adapted from (Vale, 2003) 
 
Based on phylogenetic analysis, kinesin motors are classified into fourteen families: 
kinesin 1 to kinesin 14 (Lawrence et al., 2004). In eukaryotes the different families of 
kinesin motors have specialized to perform distinct cellular functions. Most the plus end 
transport of cargos is carried out by three classes of kinesin motors: conventional 
kinesin (also called kinesin 1), heteromeric kinesin (kinesin 2), and Unc104 (kinesin 3) 
(Vale, 2003). During cell division, Kinesin-5 family of motors are involved in spindle 
assembly (Amos, 2008), and Kinesin 13 motors regulate the microtubule dynamics at 
spindle poles, which is essential for spindle bipolarity (Ganem and Compton, 2004).   
 
Tail
Motor domain
Accessory 
proteins
Kinesin-1 Dynein
25 nm
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The microtubule minus end directed motor, the cytoplasmic dynein, is the focus of this 
thesis and its structure, function and regulation will be discussed in the remaining part 
of this thesis. 
 
1.2 Dynein 
Dynein was first isolated from cilia of Tetrahymena and identified as an ATPase 
(Gibbons and Rowe, 1965). This was the axonemal dynein, responsible for beating of 
cilia and flagella. Twenty years after the discovery of the axonemal dynein, cytoplasmic 
dynein was discovered (Paschal et al., 1987; Paschal and Vallee, 1987). In humans, the 
axonemal dynein genomic family has 13 members, while with only two genes the 
cytoplasmic dynein family is not as diverse. The cytoplasmic dynein 2 is restricted to 
the cytoplasm of cilia and flagella and carries out intraflagellar transport (Pazour et al., 
1999; Porter et al., 1999); whereas several cellular functions have been ascribed to the 
single form of cytoplasmic dynein 1, referred to as ‘dynein’ hereafter. 
 
While dynein from budding yeast performs a single task of nuclear positioning, its 
metazoan counterpart performs several functions (Figure 1.5). During cell division, 
metazoan dynein plays an important role in spindle assembly for proper chromosome 
segregation. Dynein is involved in organising the minus ends of spindle microtubules 
into a focused pole (Goshima et al., 2005; Merdes et al., 2000). At kinetochores, dynein 
is required for checkpoint protein removal (Gassmann et al., 2010) and chromosome 
alignment (Mao et al., 2010). The pulling force exerted by dynein onto the cortical 
microtubules is necessary for spindle alignment (Dujardin and Vallee, 2002). During 
interphase, dynein is involved in transport of cellular cargos, which is one of the best-
studied functions of dynein (Allan, 2011; Vale et al., 2003). 
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Figure 1.5 Diverse dynein functions in cells  
During interphase (left) dynein (green spots) is involved in cargo transport from plus (+) ends of a 
microtubules (orange) to the minus ends (small arrow inside the cell indicates the direction of dynein 
motion). During cell division (right) dynein activity is required at the kinetochore, the spindle poles and 
the cell cortex (shown as green spots). The plus ends of microtubules are indicated with ‘+’ (adapted from 
Roberts et al., 2013).  
 
 
Dynein is responsible for transport of many organelles and macromolecules towards the 
microtubule minus ends (Allan, 2011). Some of the cellular cargos transported by 
dynein are: the Golgi complex (Corthesy-Theulaz et al., 1992), endoplasmic reticulum 
(Terasaki et al., 1986), endosomes (Aniento et al., 1993), mitochondria (Morris and 
Hollenbeck, 1995), and mRNPs (Schnorrer et al., 2000). Apart from these cellular 
cargoes, pathogens also hijack the dynein transport machinery (Henry et al., 2006) for 
their retrograde transport, for example: Ebola virus (van der Kant et al., 2013), Human 
Immune Deficiency virus type-1 30 (HIV1) (Lehmann et al., 2009) and Salmonella 
(Harrison et al., 2003). 
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Figure 1.6 Composition of the dynein complex 
(A) Schematic of the cytoplasmic dynein complex: Cytoplasmic dynein heavy chains (DHCs) with their 
motor and tail domains are shown, together with the non-catalytic subunits: the dynein intermediate chain 
(DIC), the dynein light intermediate chain (DLIC) and the light chains (LCs). (B) Domain organisation of 
the DHC sequence. The AAA1–AAA6 domains are in blue, the stalk with its microtubule-binding site in 
dark blue, the C-sequence in green, and the linker followed by tail in grey. The positions of the 
dimerisation region and of the binding region for the smaller subunits are indicated. Picture taken from 
(Jha and Surrey, 2015). 
 
The dynein complex is composed of six subunits that homodimerise to constitute a 1.5 
MDa sized motor (Figure 1.6 A) (Vallee et al., 1988). The complex is assembled around 
a dimer of the largest subunit of dynein, the dynein heavy chain (DHC). Each DHC 
subunit of dynein is 0.5 MDa in size and forms the catalytic subunit of dynein with a C-
terminal motor domain that hydrolyses ATP and binds to the microtubule filaments, and 
an N-terminal tail domain that allows dimerisation and interaction with other non-
catalytic dynein subunits. The remaining five subunits: the dynein intermediate chain 
(DIC), dynein light intermediate chain (DLIC) and three distinct light chains (LCs), 
AAA1 AAA2 AAA3 AAA4 AAA5 AAA6Stalk C-seqLinkerTail
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bind in pairs to the N-terminal tail of DHC (Pfister et al., 2006; Vale, 2003). While the 
DHC gene is present in single form, many isoforms of the non-catalytic subunits are 
found in cells (Pfister et al., 2006), indicating that dynein complexes with different 
subunit compositions may exist and could possibly have distinct functions.  
Our knowledge of the dynein motor domain comes from the X-ray structures of 
Dictyostelium and budding yeast dynein (Carter et al., 2011; Kon et al., 2012). Unlike 
kinesin motors with single ATP binding sites, the dynein motor consists of six distinct 
domains of AAA+ (ATPase associated with various cellular activities), AAA1–AAA6 
(Roberts et al., 2009) (Figure 1.6 B). The AAA1 domain forms the primary ATP 
hydrolysis site of dynein (Gibbons et al., 1987; Kon et al., 2004). AAA3 and AAA4 can 
also hydrolyze ATP, and the mutations in their ATP binding site hampers dynein 
motion (Cho et al., 2008; DeWitt et al., 2015; Kon et al., 2005; Kon et al., 2004). The 
AAA2, AAA5 and AAA6 do not hydrolyze ATP, however, they do play a role in 
communicating structural changes within the AAA+ ring (Schmidt et al., 2015).  
The microtubule-binding domain emanates from a long stalk projecting out of the 
AAA4 of the motor ring (Kon et al., 2012; Vale, 2003) (Figure 1.6).  Towards the N-
terminal of the AAA+ ring of dynein motor lies its linker region (Figure 1.6 B) that 
serves as a mechanical element modulating conformational changes in dynein during its 
ATPase cycle (Hook, 2010; Roberts et al., 2012) (Figure 1.7). The linker remodelling is 
crucial for dynein’s microtubule binding and unbinding that translates into dynein’s 
stepping on microtubules, and its force production (Kon et al., 2004; Kon et al., 2012; 
Roberts et al., 2012; Roberts et al., 2009).  
Although the dynein motor is generally conserved across species, there exists some fine 
structural differences: one of the most prominent differences in the dynein motor is the 
length of the C-sequence present at the C-terminal end of DHC sequence (Figure 1.6), 
which is 47 kDa in metazoan and Dictyostelium dynein and only 15 kDa in budding 
yeast dynein (Cho et al., 2008; Numata et al., 2011). This difference has been recently 
suggested to cause differences in motile properties of dynein (Nicholas et al., 2015) and 
will be discussed further in Chapter 2. 
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Figure 1.7 Enzymatic cycle of dynein 
The dynein enzyme undergoes a series of changes in its microtubule binding and linker rearrangement in 
different nucleotide stage of its ATP hydrolysis cycle. The AAA1 domain forms the primary ATP 
binding site (indicated in the diagram) and the linker (shown in pink) changes its conformation that 
translates into stepping and force production. 1. In the absence of ATP dynein is tightly bound to the 
microtubule (MT). 2. Upon ATP binding MT affinity of dynein weakens resulting in dissociation of 
dynein from MT. 3. In the ATP bound state and as ATP hydrolyses to ADP+Pi the linker domain changes 
its conformation relative to the AAA ring. This linker remodeling shifts the dynein’s microtubule binding 
domain forward to bind (stepping) MT at new site. 4. Upon ATP hydrolysis, when ADP.Pi (inorganic 
phosphate) is bound to dynein, it rebinds the MT at a new site by weak MT interaction. 5. Once Pi 
releases, dynein binds the MT strongly and the linker again changes its conformation. The conformational 
change in linker and high MT binding in ADP state is thought to represent dynein’s force producing state 
known as its ‘powerstroke’. ADP then releases from the nucleotide-binding pocket of dynein restarting 
the cycle. Adapted from (Roberts et al., 2013) 
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Motile properties of dynein 
In vitro assays using dynein purified from diverse organisms have provided precise 
measurement of several properties of dynein. One of the first in vitro experiments to 
study dynein activity was microtubule gliding assay with purified surface-immobilized 
dynein that transported microtubules by their ensemble activity (Paschal and Vallee, 
1987). Whereas, single dynein properties are studied through two approaches: bead 
assays—where dynein is adsorbed onto micrometer-sized plastic beads and bead 
motility is visualised by microscopy (Culver-Hanlon et al., 2006; King and Schroer, 
2000; Mallik et al., 2005; McKenney et al., 2010; Toba et al., 2006; Wang et al., 1995); 
and the second method involves direct visualisation of labelled dynein by single 
molecule fluorescence microscopy (McKenney et al., 2014; Numata et al., 2011; Reck-
Peterson et al., 2006; Schlager et al., 2014; Trokter et al., 2012). Using these assays, 
velocities of dynein from different species has been measured showing that 
Dictyostelium and metazoan dynein move (ranging from 0.3 to 1 µm/s) much faster than 
budding yeast dynein (~0.1 µm/s) (reviewed in (Jha and Surrey, 2015)).  
Force measurement of dynein studied through laser trapping experiments also showed 
organism-specific differences: while force measured for single vertebrate dynein was 1–
2 pN (Mallik et al., 2004; McKenney et al., 2010; Schroeder et al., 2010; Vershinin et 
al., 2008) force exerted by budding yeast dynein was up to ∼7 pN (Gennerich et al., 
2007). These variations in velocity and force production indicate that dynein shows 
species-specific dissimilarities, and some of these differences are suggested to arise 
from fine structural differences (Nicholas et al., 2015) in dynein from different species. 
 
Processivity 
For long-range retrograde cargo transport, dynein moves at a micron-scale before 
detaching from the microtubule—referred to as ‘processivity’ of a motor. In vitro 
evidence of processivity came from studying the motility of salt washed vesicles and 
plastic beads coated with purified brain dynein imaged by video enhanced DIC 
microscopy (Gill et al., 1991; Wang et al., 1995). Utilizing the genetically tractable 
lower eukaryotes, such as budding yeast (Reck-Peterson et al., 2006) and Dictyostelium 
(Numata et al., 2011) recombinant dyneins were generate. This allowed direct 
visualization of processive dynein motion by fluorescence microscopy. Single molecule 
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fluorescence imaging of recombinant dynein complex form budding yeast exhibited 
processive behavior (Kardon et al., 2009; Reck-Peterson et al., 2006). To dissect out the 
molecular mechanism of processivity, an artificially dimerised (using GST tag) and 
fluorescently labelled truncated DHC constructs lacking the N-terminal dynein tail were 
generated (Reck-Peterson et al., 2006). The budding yeast dynein dimers showed 
processively in vitro (Reck-Peterson et al., 2006); and, their processivity required intact 
dynein linker domains and dimerisation (Reck-Peterson et al., 2006). Similar 
recombinant dynein dimers from Dictyostelium moved processively when studied by 
single-molecule fluorescence imaging (Numata et al., 2011), and required dimerisation 
of dynein motor for processivity. Additionally, coordination between the two motor 
heads of dynein dimer was also required for processivity of Dictyostelium dynein; this 
co-ordination was attributed to the C-sequence of dynein motor (Numata et al., 2011), 
which is missing in budding yeast dynein.  
In stark contrast to recombinant dynein from lower eukaryotes, fluorescently labelled 
full-length vertebrate dynein from cultured cells (Mazumdar et al., 1996; McKenney et 
al., 2014) or expressed in insect cells (Schlager et al., 2014; Trokter et al., 2012) lacked 
processivity when studied through fluorescence microscopy. The artificially dimerised 
vertebrate dynein fragments also showed nonprocessive behavior in single molecule 
fluorescence imaging experiments (Jha and Surrey, 2015; Nicholas et al., 2015; Trokter 
et al., 2012). These observations challenged the long-standing notion of processivity 
being an inherent property of dynein motor across species. It became apparent that 
unlike dynein from lower eukaryotes, vertebrate dynein is nonprocessive and the 
possible reason behind this was suggested to be inhibition of dynein motor (Carter et al., 
2016; Torisawa et al., 2014; Urnavicius et al., 2015)(discussed further in Chapter 2). 
How does the nonprocessive metazoan dynein drive long-range intracellular transport? 
Metazoan dynein interacts with many proteins that are known to regulate its several 
motile properties, including processivity (Kardon and Vale, 2009). One of the best 
studied regulators of dynein is the dynactin complex, crucial for almost all dynein-
driven cellular activities (Schroer, 2004).  
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1.2.1 Dynein regulator: Dynactin 
Dynactin was first studied as a co-purified /contaminant protein present in purified brain 
dynein that activated the dynein motility of salt-washed organelles1, and was therefore 
named a dynein activator—dynactin (Gill et al., 1991; Paschal et al., 1993; Schroer and 
Sheetz, 1991b). Some of the cellular dynein functions where dynactin has been studied 
to be important are: recruitment of dynein to Golgi (Holleran et al., 2001; Holleran et al., 
1996; Muresan et al., 2001), ER (Zong et al., 2012; Watson et al., 2004), endosomes 
(Johansson et al., 2007); nuclear envelope breakdown (Salina et al., 2002) spindle 
alignment at cortex (Kiyomitsu and Cheeseman, 2012; Kotak et al., 2012); and spindle 
pole focusing (Gaglio et al., 1997; Merdes et al., 2000; Merdes et al., 1996).  
The large scale purification of dynactin from brain tissues (Bingham et al., 1998) 
enabled analysis of its structure and subunit composition (Schroer, 2004). The dynactin 
complex is composed of eleven different subunits with distinct stoichiometry assembled 
into a megadalton-sized multi-protein complex (Eckley et al., 1999; Imai et al., 2006; 
Schafer et al., 1994; Schroer, 2004). So far, the metazoan dynactin complex has mainly 
been purified from neuronal sources (Bingham et al., 1998; Schroer and Sheetz, 1991b; 
Urnavicius et al., 2015); large-scale purification from non-neuronal sources has not 
been reported, possibly due to low abundance of dynactin in non-neuronal cells. 
Furthermore the complicated subunit stoichiometry of the dynactin complex (Schroer, 
2004) and insolubility of some of its subunits, for example, Arp1 (Cheong et al., 2014) 
and p150 (Moughamian et al., 2013), have prevented reconstitution of full-length 
recombinant dynactin complex.   
Recent high resolution EM structure further elucidated the complex architecture of 
dynactin (Figure 1.8) (Chowdhury et al., 2015; Urnavicius et al., 2015). The dynactin 
complex is assembled around a polarized filament of Actin-related protein-1—Arp1. 
The polymer of Arp1 proteins is capped by actin capping proteins at one end (barbed 
end); and has p25/27 and p62 subunits at another end (pointed end) (Figure 1.8). The 
p50 (dynamitin) subunits forms the shoulder and extends onto the Arp1 filament to 
scaffold each of the eight Arp1 monomers; this scaffolding is hypothesized to be 
important for determining the length of Arp1 filament (Figure 1.8). The p50 subunit 
                                                1	Treatment with 600mM potassium iodide removed the native proteins presented on the 
organelle (Schroer et al., 1988)	
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also links the largest dynactin subunit–p150glued (referred as p150 hereafter) to the rest of 
the dynactin structure (Figure 1.8).  
 
 
Figure 1.8 Schematic of the dynactin complex  
The Arp1 filament (grey) has 8 Arp1 monomers labelled 1-8 capped with CapZ αβ towards the barbed 
end, and the p25/p27 (brown), and p62 (orange) subunits are present towards the pointed end. The 
filament also contains β-actin (dark grey) and Arp11 (yellow).  The shoulder region (purple) contains p24 
and p50 subunits.  The purple dashed line below the Arp1 filament is thought to be an extended p50 
region. The blue and red filaments protruding from the shoulder is the p150/p135 subunits, which consists 
of three coiled-coil (CC) domains, CC1A, CC1B and CC2, a globular domain known as Inter coiled-coil 
domain (ICD) is present between CC2 and CC1. The full-length p150 appears to be folded and docked 
onto the Arp1 filament.  Dynactin is known to interact with dynein at two different sites; the CC1B 
domain and Arp1 filament (indicated in bold). But these interactions require additional cofactor that 
would undock the p150. The microtubule and EB1 binding CAP-Gly domain was not visible in the 
structure, but based on the orientation of p150 it is predicted to be buried between Arp1 filament and rest 
of the folded p150 (predicted CAP-Gly position shown with dashed line). Adapted from (Urnavicius et al. 
2015). 
 
Intriguingly, although dynactin copurifies with dynein from native sources (Bingham 
et al., 1998), mixing pure dynactin and dynein in solution does not show any detectable 
interaction (Mckenney et al., 2014; Schlager et al., 2014). Our understanding of the 
dynein-dynactin interaction mainly comes from immunoprecipitation (Vaughan and 
Vallee, 1995) and solution binding experiments (King et al., 2003) with the truncated 
fragments of the dynein and dynactin subunit. These experiments have shown that the 
CC1 domain of p150 interacts with the N-terminal of DIC subunit of dynein (Karki and 
Holzbaur, 1995; King et al., 2003; Siglin et al., 2013; Vaughan and Vallee, 1995). The 
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p150 subunit of dynactin also contains the microtubule binding and +TIPs binding—
CAP Gly domain (Askham et al., 2002; Ligon et al., 2003).  
Surprisingly, the recent dynein structure shows p150—the hub of interaction sites, in a 
folded conformation, where p150 sits in the groove of Arp1 filament (Carter et al., 
2016; Urnavicius et al., 2015) (Figure 1.8). In this conformation, the dynein binding 
CC1 domain and the microtubule binding CAP-Gly domain appear to be inaccessible 
for interaction. This folded conformation of p150 is believed to represent an auto-
inhibited state of dynactin, and in this conformation, its interaction with dynein is 
supposed to be weak (Carter et al., 2016; Urnavicius et al., 2015). The exact position of 
the microtubule and +TIP binding CAP-Gly domain in the current dynactin structure is 
unclear. However, based on the projection of the coiled-coil domains of p150 it is 
predicted to be buried in the Arp1 groove (Urnavicius et al., 2015) (Figure 1.8). The 
proposed mechanism for the release of auto-inhibition of dynactin and its complex 
formation with dynein (Chowdhury et al., 2015; Urnavicius et al., 2015) will be 
discussed later in this Chapter. 
While the interaction site of dynactin lies at the dynein tail domain, Lis1–another 
ubiquitous dynein regulator can bind directly to the motor domain to control several 
dynein functions.  
 
1.2.2 Dynein regulator: Lis1 
Lissencephaly1 or Lis1 is one of the most well conserved regulators of dynein across 
species. The first report of dynein regulation by Lis1 came from studies in filamentous 
fungi, where it was known to regulate dynein in nuclear migration (Efimov and Morris, 
2000; Minke et al., 1999; Xiang et al., 1995), In mammalian cells, Lis1 is involved in 
several dynein functions ranging from pole focusing (Raaijmakers et al., 2013; 
Zylkiewicz et al., 2011), recruiting dynein to kinetochores (Faulkner et al., 2000) , 
chromosome alignment (Stehman et al., 2007; Vergnolle and Taylor, 2007), and 
organelle transport (Lam et al., 2010; Liang et al., 2004; Pandey and Smith, 2011; 
Smith et al., 2000; Splinter et al., 2012)  
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Figure 1.9 Schematic of Lis1  
Lis1 is a dimeric protein that contains 7 WD-40 repeats towards the C-terminal which is a ß-propeller 
structure (shown in the right-hand side schematic). Each WD40 domain interacts with one dynein AAA+ 
ring.  The LisH (Lis1 homology) and the cc (coiled-coil) domain present at the N-terminal allow the 
dimerisation of Lis1 (Kim et al., 2004; Tarricone et al., 2004). Adapted from (Kardon et al., 2009) 
 
  
Lis1 is 45kDa protein that dimerises via its N terminal coiled-coil region (Mateja et al., 
2006) and interacts with dynein through its C-terminal WD repeats (Figure 1.9), which 
binds the DHC subunit at AAA+ ring (Huang et al., 2012; Kim et al., 2004; Tai et al., 
2002; Tarricone et al., 2004). The exact location of Lis1’s interaction site was 
previously reported to be AAA1 domain (Tarricone et al., 2004), however, the 
subsequent EM structure suggests that Lis1 binds at the interface of AAA3/4 (Huang et 
al., 2012; Toropova et al., 2014).  Lis1 is the only known dynein regulator that binds to 
the dynein motor domain directly (Toropova et al., 2014). 
Lis1 acts together with another protein—nuclear distribution E/L (NudE/L) that binds 
to the dynein tail region to provide an additional layer of regulation(Efimov and Morris, 
2000; Sasaki et al., 2000; Stehman et al., 2007). While some reports suggest that Lis1 
and NudE/L may antagonistically regulate dynein (McKenney et al., 2010; Torisawa et 
al., 2011; Yamada et al., 2008), several reports have demonstrated that their regulation 
is synergistic, and increasing Lis1 concentration compensates for the absence of 
NudE/L activity both in cells and in vitro (Efimov, 2003; Huang et al., 2012; Li et al., 
2005; Shu et al., 2004; Wang et al., 2011; Wang et al., 2013; Zylkiewicz et al., 2011). 
Lis1 has also been reported to interact with dynactin’s p50 subunit (Tai et al., 2002), 
indicating that it may regulate the dynein-dynactin complex. 
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Besides the ubiquitous dynein regulators dynactin and Lis1, several adaptor proteins 
that recruit dynein to various cellular structures (e.g. cargo membranes, cell cortex, 
nuclear envelope) also regulate dynein transport (Kardon and Vale, 2009).  For 
metazoan dynein one of the conserved regulator is BicD adaptor protein.  
 
1.2.3 Dynein regulator: BicD2 
Bicaudal-D (BicD) is a metazoan-specific cargo adaptor protein that links dynein to the 
membranes of organelles (Kardon and Vale, 2009). It is best known for its role in 
mRNA transport in Drosophila (Bullock and Ish-Horowicz, 2001). There are two 
homologues of BicD in mammals—BicD1 and BicD2 (Terenzio and Schiavo, 2010). 
BicD2 is better characterized for its role as cargo adaptor for dynein driven transport. It 
is largely a coiled-coil protein with three coiled-coil domains that bind to crucial 
components of bidirectional transport: the dynein-dynactin complex, kinesin-1, and Rab 
receptors present on vesicles (Figure 1.10) (Splinter et al., 2012; Splinter et al., 2010). 
                       
Figure 1.10 Schematic of BicD2 protein 
BicD2 is largely coiled-coil (cc) in structure, and consist of three cc domains. The numbers represent the 
amino acid position. The binding partners are mentioned on top of the protein scheme. The CC1 binds to 
the dynein-dynactin complex, the CC2 binds to kinesin-1, and the CC3 interacts with Rab proteins 
present on the membrane of cargoes. CC3 has also been shown to bind to p50 subunit of dynactin. The 
CC1 and the CC3 bind to each other for BicD2 autoinhibition. BicD2-N fragment of N-terminal 1-400 
amino acid used for previous in vitro reconstitution experiments and in this study is indicated below the 
molecular scheme.   
 
The full-length BicD2 is known to show intramolecular inhibition, where its N-terminal 
CC1 binds to the C-terminal CC3 to assume a folded conformation (Figure 1.10) 
(Hoogenraad et al., 2001; Stuurman et al., 1999). Owing to this autoinhibition of full-
length BicD2, an N-terminal fragment of BicD2 (Figure 1.10) is generally used for 
CC1 CC2 CC3
    1    20     269   338   537   566   808   824
Dynein-Dynactin Kinesin-1
Rab6
BicD2-CC1BicD2-CC3
Dynactin-p50
    1   400
BicD2-N fragment
Chapter 1 Introduction 
 30 
biochemical and structural studies of dynein regulation (Chowdhury et al., 2015; 
McKenney et al., 2014; Schlager et al., 2014; Urnavicius et al., 2015). Recently, point 
mutations in BicD has also been linked to spinal muscular atrophy (Neveling et al., 
2013; Oates et al., 2013), and some of these mutations were shown to enhance its 
interaction with dynein-dynactin (Oates et al., 2013). In the context of organelle 
transport, the possible effects of enhanced dynein-dynactin binding by mutant BicD2 
remains to be studied.  
 
1.3 Regulation of motile properties of dynein 
1.3.1 Regulation by Dynactin 
Several conflicting observations have been reported for the role of dynactin in 
regulation of dynein motion. In vitro bead assays using purified mammalian dynein and 
dynactin reported a modest twofold increase in dynein run length, and attributed this 
increase to the microtubule binding CAP-Gly domain of dynactin (Culver-Hanlon et al., 
2006; King and Schroer, 2000). Similar increase in processivity was also observed by 
fluorescence imaging of yeast dynein-dynactin complex (Kardon et al., 2009), however, 
the CAP-Gly domain was not important for this processivity enhancement. Further, 
deletion of the CAP-Gly domain of p150 did not affect dynein driven organelle 
transport in insect cells (Kim et al., 2007) HeLa cells and (Dixit et al., 2008) neurons 
(Moughamian and Holzbaur, 2012). Dynactin has also been shown to induce 
bidirectional dynein motion in a study using fluorescent dynein-dynactin complex 
purified from GFP-p50 expressing transgenic mice (Ross et al., 2006), however, the 
dynein motion in this study appears rather diffusive than processive. 
Recent reports suggest that vertebrate dynactin complex shows weak binding to the 
microtubule and dynein and does not activate processivity of the nonprocessive 
vertebrate dynein (Mckenney et al., 2014; Schlager et al., 2014). Furthermore, 
vertebrate dynactin does not affect the ensemble microtubule gliding velocity of 
purified dynein (Wang et al., 2013). Overall, the vertebrate dynactin complex is not a 
strong regulator of processive dynein motion when studied in the absence of other 
dynein regulators (Mckenney et al., 2014; Schlager et al., 2014).  
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1.3.2 Regulation by Dynactin and BicD2 
Recent in vitro experiments revealed that processive motion of vertebrate dynein 
requires two components: the dynactin complex and a cargo adaptor BicD2-N (an N-
terminal fragment of BicD2) (Figure 1.10). BicD2-N facilitates the dynein-dynactin 
interaction, to form a dynein-dynactin-BicD2 (DDB) complex with highly processive 
motility (up to 10 μm) (McKenney et al., 2014; Schlager et al., 2014). Besides BicD2-
N, other cargo adaptors such as: kinetochore adaptor Spindly (Griffis et al., 2007), 
endosome adaptors Rab11-FIP3 (Horgan et al., 2010), and Hook3 (Zhang et al., 2014) 
also activates the processive motion of human dynein in the presence of dynactin 
(McKenney et al., 2014). Therefore, a general mechanism of activation of dynein 
motion was proposed where processivity is activated when dynein binds to the cargos 
via cargo adaptors and dynactin (McKenney et al., 2014) (Figure 1.11).  
 
 
Figure 1.11 Schematic representations of processivity activation of dynein by dynactin and 
BicD2  
When bound to cargo (grey), cargo adaptor proteins like BicD2 (shown in purple) transform 
nonprocessive mammalian dynein (left) to processive dynein (right). Picture taken from (Jha 
and Surrey, 2015). 
 
Formation of the DDB complex is suggested to produce rearrangements in dynein and 
dynactin structures to activate dynein and unfold the p150 subunit dynactin to allow the 
interaction of the CAP-Gly domain with the microtubule (Carter et al, 2016; 
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Chowdhury et al., 2015; Urnavicius et al., 2015). The structural basis of stabilisation 
and processivity enhancement of dynein-dynactin by BicD2-N was elucidated recently 
through cryo EM and negative-stain EM (Chowdhury et al., 2015; McKenney et al., 
2014; Schlager et al., 2014; Urnavicius et al., 2015).  
 
 
 
 
Figure 1.12 Structure of the DDB complex 
The cryo-EM structure of dynein tail-dynactin-BicD2-N complex (Left). Schematic representations 
(right) showing formation of DDB complex where BicD2-N is sandwiched between dynein tail and 
dynactin’s Arp1 filament. Picture taken from (Urnavicius et al., 2015). 
 
Attachment of BicD2 to the dynein-dynactin complex was suggested to activate dynein 
and dynactin by the following mechanism: 
1. Activation of dynein: BicD2-N binds along the length of the dynactin Arp1 
filament and forms an interaction interface with the dynein tail (Figure 1.12) 
(Urnavicius et al., 2015). However, the two dynein tails bind asymmetrically to 
the Arp1 filament. The asymmetry introduced in the dynein tail is expected to 
cause separation of dynein motor heads, which is known to release dynein’s auto 
inhibition (Torisawa et al., 2014) and activate dynein processivity.  
2. Activation of dynactin:  The binding of BicD2-N to the Arp1 is also suggested 
to undock the p150 subunit, which was folded in the groove of the Arp1 
filament (Figure 1.9). The unfolding of p150 is thought to expose the CC1 and 
Dynactin
Dynein
BicD2-N
Arp1 filament
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the CAP-Gly domain, which allows the dynein-dynactin (Karki & Holzbaur 
1995, King et al., 2003, Siglin et al., 2013, Vaughan & Vallee, 1995) and the 
dynactin-microtubule interactions. 
 
 
Intriguingly, expression of BicD2-N fragment did not lead to processive dynein motion 
in cells, unless this fragment was directly coupled to cargos (Splinter et.al, 2012). The 
reason behind this lack of dynein processivity in BicD2-N expressing could be 
competition with endogenous cargo adaptors.  Moreover, a neuronal isoform BicDR-1 
coupled to Rab positive vesicles lead to an increase in the velocity of dynein-driven 
vesicle transport in cells (Schlager et al., 2014b). Additionally, in bead assays with 
purified proteins, attachment of BicD2 and dynactin also increased the velocity of 
dynein (Belyy et al., 2016). Whether this effect is specific to BicD2 or can be 
generalized to other cargo adaptors remains to be studied. Formation of DDB complex 
lead to enhancement of yet another motor property of mammalian dynein: its force 
production (Belyy et al., 2016). When DDB complex was attached to the beads, it 
exerted a force fourfold higher than dynein. This high force production further enabled 
dynein to compete in the tug-of-war with single kinesin-1 motor without the need of 
teaming up of many dynein motors, as previously report (Rai et al., 2013). 
To summarize, vertebrate dynein alone seems to be a nonprocessive motor with weak 
affinity for microtubules and generates low force. Adding dynactin to this weak motor 
does not cause any noticeable change in its motile properties. Nevertheless, when 
dynactin is attached via cargo adaptor BicD2 to vertebrate dynein, it enhances several 
motile properties of dynein to generate an extremely processive, high force producing 
motor. 
 
1.3.3 Regulation by Lis1 
The mechanism of Lis1 regulation is best characterized in yeast where Lis1 is known to 
increase the processivity of yeast dynein by increasing its microtubule affinity (Huang 
et al., 2012). For vertebrate dynein, while Lis1 alone had no effect on processivity of 
dynein, Lis1 and NudE together increased the processivity of dynein in bead assays 
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(McKenney et al., 2010). Furthermore, Lis1 reduced the speed of dynein for both yeast 
and mammalian dynein (Yamada et al., 2008; McKenney et al., 2010; Huang et al., 
2012). Lis1 also increased the microtubule affinity of both fungal and vertebrate dynein 
(Huang et al., 2012; McKenney et al., 2010; Toropova et al., 2014; Yamada et al., 
2008). A clutch like role of Lis1 was proposed to be responsible for this enhanced 
microtubule attachment. Lis1 seems to restrict the movement of the dynein linker 
(Figure 8) (Toropova et al., 2014), which is crucial for dynein’s microtubule binding 
and unbinding as ATP is hydrolysed (Figure 8) (Toropova et al., 2014; Huang et al., 
2012). Thus, the increase in microtubule affinity of dynein by Lis1 is not due to 
blocking its ATP activity but due to restriction in conformational change of dynein 
motor (Figure 1.13). 
 
 
 
Figure 1.13 ATPase cycle of the dynein-Lis1 complex 
Lis1 binds to the dynein AAA+ ring (at AAA3/4) and blocks the stages of linker movement that 
originally occurs during ATPase cycle, ultimately blocking the microtubule release of dynein.  The linker 
can move up to a certain extent upon ATP hydrolysis (close to AAA2) (referred to as ‘Linker swing’ in 
the figure). However, Lis1 sterically blocks the linker's return to its normal position (closed to AAA5) on 
dynein's ring that is essential for microtubule binding and unbinding of dynein. (Black outline schematic 
represents steps in dynein ATPase cycle skipped by dynein-Lis1)   
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In the presence of Lis1, metazoan dynein generates high persistent force (McKenney et 
al., 2010), suggesting dynein adapts to sustain high load. An in vivo evidence of high 
load adaptation of dynein-Lis1 came from the observation in rat cortical neurons where 
blocking Lis1 activity by a functional blocking antibody specifically hampered the 
transport of large lysosomes (>1 µm), while the transport of small-sized lysosomes 
remained unaffected (Yi et al., 2011). In contrast, Lis1 knockdown in mouse DRG 
neurons using siRNA against Lis1, blocked transport of many cargoes, including 
lysosomes, independent of the cargo size (Moughamian et al., 2013).  Whether this 
difference in cargo-size-related Lis1 regulation arises due to the technique used to 
inhibit Lis1 activity in the two studies remains to be tested.  
Furthermore, while Lis1 is essential for cargo transport in mammalian cells and in 
fungi, its interaction with dynein appears weak, and in some cases, specifically bound to 
mammalian dynein in ADP state (McKenney et al., 2010). Recently, Lis1 was 
suggested to remain bound to dynein under high load on lipid droplets isolated from 
cultured mammalian cells, although Lis1 was not directly imaged in this study (Reddy 
et al., 2016). Further in vitro characterization of dynein-Lis1 interaction is required 
using fluorescently tagged proteins to conclusively comment on the nature of their 
interaction. 
Taken together, these observations suggest that Lis1 acts as an inhibitor of dynein 
motion, since it reduces the velocity and clamps dynein onto the microtubules. 
Furthermore, Lis1 was shown to be essential for dynein-driven transport of BicD2 
positive cargoes in cells, however, the impact of Lis1 regulation on DDB motion has 
not been studied in vitro. 
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1.4 Dynein at microtubule plus ends 
Dynein from diverse organisms have been observed to localise at the plus ends of 
dynamic microtubules (Table1) (Fujita et al., 2015; Han et al., 2001; Kobayashi and 
Murayama, 2009; Lenz et al., 2006; Ma and Chisholm, 2002; Schuster et al., 2011; 
Sheeman et al., 2003; Vaughan et al., 1999). The dynamic microtubule plus ends are 
important sites of dynein activity during cell division and dynein-driven transport. At 
plus ends, +TIPs have been suggested to promote the initial interaction of cargos with 
microtubules (Moughamian et al., 2013; Pierre et al., 1992; Vaughan et al., 2002). 
During cell division, dynein interacts with the plus ends of the cortical and kinetochore 
microtubules where its activity appears to be essential for spindle positioning (McGrail 
and Hays, 1997; Moore et al., 2009), chromosome alignment (Varma et al., 2008) and 
checkpoint protein removal (Griffis et al., 2007). Dynein is hypothesized to tether 
microtubule plus ends and exert a pulling force onto cortical microtubules for spindle 
positioning, which was also demonstrated in vitro by studying pulling of microtubule 
plus ends by bead or barrier immobilized dynein (Hendricks et al., 2012; Laan et al., 
2012).  
Mechanism of plus end localisation of dynein 
There are two known molecular pathways by which dynein accumulates at the 
microtubule plus ends (Table 1):  plus end transport by kinesin motors, and dynactin-
dependent plus end tracking. Broadly, the major difference between the two pathways is 
that the former pathway involves a vectorial anterograde transport of dynein by plus end 
directed motor, while the latter involves recruitment of dynein from the cytoplasmic 
pool by +TIPs. However, mixed versions of these pathways also exist in some systems 
and will be discussed further in this section. 
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Table 1: Molecular players of dynein’s plus end localisation in different organisms 
summarized from some of the in vivo studies (and two in vitro studies). +TIP dependent 
plus end tracking highlighted with grey, and in some systems, such as Ustilago and 
neurons, both plus end tracking and plus end transport of dynein has been reported. 
 
* A sub-population of dynein is maintained at plus ends by dynactin-EB1 dependent end tracking and 
another dynein pool is brought to plus end through transport by kinesin-1 in U.maydis (Schuster et al., 
2011) 
 
 
1.4.1 Plus end transport of dynein 
In lower eukaryotes plus end accumulation of dynein is brought about by kinesin driven 
transport (Table 1) (Carvalho et al., 2004; Zhang et al., 2003). Evidence of kinesin-
dependent plus end transport of dynein was observed in budding yeast where the 
necessary components were: Kip2 (Kinesin 7), Pac1 (Lis1), and Bik1 (Clip170) 
(Carvalho et al., 2004; Lee et al., 2003; Sheeman et al., 2003)). Further mechanistic 
S. cerevisiae
A.nidulans
S. pombe
U.maydis
of 
plus end localisation
Expected functions 
at plus ends
References
Non-neuronal
Mammalian cells
Organism
Kip2,Pac1 & Bik1
Spindle positioning
transport initation
Ssm4 (p150 homolog)
 Dynein predominantly 
on shrinking plus ends
KinA(Kinesin-1 homolog) 
& dynactin
(Han et al., 2001; Lenz et al., 2006; 
Xiang, 2000; Zhang et al., 2003; )
Kinesin-1,dynactin &Lis1
 
 dynactin &EB1*
Mammalian
Neurons Dynactin, CLIP170 
& EB1
Dynactin, Lis1, CLIP170
& EB1
Kinesin-1 & Lis1
(Fujita et al., 2015)
(Coquelle et al., 2002; 
Splinter et al., 2012 )
Cargo loading 
& transport initation
p150  fragment & EB1
Kip2, Pac1,Bik1 & Bim1
(Duellberg et al. 2014)
(Roberts et al. 2014)
Nuclear positioning 
during hyphal growth 
In vitro
In vitro
Cargo loading 
& transport initation
&
(Yamada et al., 2008)
Essential components
Spindle alingnment.,
Chromosome separation, 
& tranport initiation
(Lloyd et al. 2012; Lomakin et al. 2009; 
Moughamian et al. 2013; Moughamian 
& Holzbaur 2012; Nirschl et al., 2016)
(Lenz el al., 2006; Schuster et al., 2011)
(Carvalho et al. 2004; Lee et al. 2003;
 Sheeman et al. 2003)
Nucleat migration
(Schuster et al., 2011)
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details of this pathway were elucidated through in vitro reconstitution using purified 
proteins (Roberts et al., 2014). Kip2 transported a dimeric yeast dynein fragment, where 
processive yeast dynein showed a tug-of-war with Kip2. To bias the net transport in 
plus end direction, Bim1 and Bik1 acted as the processivity factors for Kip2, while 
Pac1-Bik1 interaction connected dynein and Kip2 (Figure 1.14). Kinesin-dependent 
plus end transport of dynein has also been reported in Aspergillus (Egan et al., 2012; 
Lenz et al., 2006; Zhang et al., 2003). However, dynactin was required for its plus end 
transport, and although Lis1 did accumulate at plus ends, it was redundant for plus end 
tracking (Egan et al. 2012). Additionally, in DRG neurons kinesin-1 was reported to 
transport dynein to the plus ends in the presence of Lis1 (Yamada et al., 2008), where 
Lis1 was shown to act as a repressor of dynein motion to enable its effective plus end 
transport.  
 
 
Figure 1.14 Plus end transport of yeast dynein 
An artificial yeast dynein dimer is transported by the kinesin-7, Kip2 in the presence of the LIS1 
homologue Pac1 and the CLIP-170 homologue Bik1. Additionally, the EB1 homologue Bim1 increases 
the processivity of plus end-directed Kip2-dependent dynein transport (Roberts et al., 2014). Picture 
taken from (Jha and Surrey, 2015). 
 
 
1.4.2 Plus end tracking of dynein 
A second pathway responsible for dynein’s plus end accumulation requires dynactin 
and end binding proteins–EB1 and CLIP170. This pathway seems to be more prevalent 
in metazoans (Table 1). Several studies have established that the plus end tracking of 
dynein requires dynactin, CLIP170 and EB1 in neurons (Lloyd et al., 2012; Lomakin et 
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al., 2009; Moughamian and Holzbaur, 2012; Moughamian et al., 2013; Nirschl et al., 
2016). However, both dynactin and Lis1 seems essential for dynein’s plus end tracking 
in non-neuronal cultured cells (Coquelle et al., 2002; Splinter et al., 2012). 
Contradictory to this evidence, another study in non-neuronal cells suggested that 
dynein-dynactin localisation at kinetochore is independent of Lis1; instead, Lis1 
requires dynein-dynactin for its plus end localisation (Tai et al., 2002). Whether the 
dependency of dynein and its regulator for their plus end localisation varies with the 
cell-type or in a cell-cycle-stage specific manner is not well understood.  
 
Figure 1.15 Plus end tracking of the recombinant human dynein complex 
The human dynein complex interacts via dynein intermediate chain binds to the CC1 (coiled-coil1) of 
p150, the p150 CAP-Gly (SxIP-motif containing) domain interacts with EB1 (at EEY/F motif), the 
autonomous microtubule plus end binding protein that binds to the growing microtubule plus ends. In the 
presence of (other SxIP proteins) competitors for EB1 binding, p150 can also interact with EB1-recruited 
CLIP-170 (at EEY/F Zinc knuckle domain) where other SxIP proteins do not bind, thus providing an 
alternative interaction route for p150 and dynein (Duellberg et al. 2014). Picture taken from (Duellberg et 
al. 2014). 
 
Furthermore, in vitro reconstitution study showed that the recombinant human dynein 
localises to the microtubule plus ends in the presence of EB1 and a fragment of p150 N-
terminal 1-517(p1501-517) (Figure 1.15) (Duellberg et al., 2014). Additionally, in the 
presence of competing EB1 binding SxIP peptides, p150 interacted with CLIP170 
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recruited by EB1 at plus ends, thereby providing an alternate pathway for plus end 
localisation of dynein (Figure 1.15). However, a p1501-517 fragment and the full-length 
p150 of the dynactin complex may show differences in their interactions with dynein 
and EB1 because to the folded conformation of the full-length p150. Whether the full-
length p150 integrated to the dynactin complex can bind to EBs to track plus ends and 
recruit dynein to the plus ends remains to be studied. Moreover, Lis1 was not required 
for the plus end tracking of the recombinant human dynein. This could be because 
recombinant human dynein is naturally nonprocessive in vitro and does not require 
repression of motion by Lis1.  On the other hand, in cells where dynein is processive, 
Lis1 was required for the dynactin-dependent plus end tracking of dynein (Coquelle et 
al., 2002; Splinter et al., 2012). Whether in vitro Lis1 is needed for plus end localisation 
of dynein in the presence of processivity factors remains to be tested. 
To summarize, the plus end localisation of dynein involves two pathways: the vectorial 
transport by kinesin motors, which is well studied in lower eukaryotes and dynactin 
dependent plus end tracking studied in metazoans. In vitro reconstitution of plus end 
localisation of vertebrate dynein has identified EB1 and p150 fragment as necessary 
component (Duellberg et al., 2014), however, to fully grasp the mechanism of plus end 
tracking in physiological scenario, reconstitution with the full-length dynactin complex 
and Lis1 is required. 
 
 
1.5 Initiation of dynein transport 
In cells, dynactin and Lis1 have both been observed to play a role in initiation of dynein 
transport. The interaction of Lis1 and dynactin with CLIP170 seems to be crucial for 
loading dynein onto cargos at microtubule plus ends (Coquelle et al., 2002; Ligon et al., 
2006; Pierre et al., 1992; Valetti et al., 1999; Vaughan et al., 1999). However, in 
mammalian cells, depletion of CLIP-170 had no effect on endosome movement 
(Watson and Stephens, 2006). Another study reported a site-specific regulation of 
initiation in neurons, where p150, specifically its CAP-Gly domain, was essential for 
initiation of Rab-positive and LAMP1-positive vesicle transport from the plus ends of 
distal neurites, while Lis1 was required for transport initiation along the entire length of 
Chapter 1 Introduction 
 41 
the axonal microtubule (Moughamian et al., 2013). Lis1 was also shown to initiate 
transport of endosomes and peroxisomes in Aspergillus (Lenz et al., 2006; Egan et al., 
2012). Whether Lis1 is a constitutive initiator of dynein transport and p150 acts as an 
initiator only at plus ends remains to be studied.   
Two recent reports have characterised the mechanism of dynactin dependent initiation 
of dynein transport in vitro (McKenney et al., 2016; Nirschl et al., 2016). Dynactin, 
especially its microtubule binding CAP-Gly domain, showed a preference for 
tyrosinated tubulin patches. The C terminal tail of alpha tubulin of freshly polymerized 
microtubule plus ends is tyrosinated (Janke, 2014), to which CAP-Gly proteins bind. 
Using recombinant yeast tubulin (lacks post-translational modification), McKenney et 
al., 2014, generated microtubule with fused stretches conataining detyrosinated and 
tyrosinated α tubulins. While purified metazoan dynein bound to either of the modified 
tubulin patches, the metazoan p150 of dynactin was specifically enriched on the 
tyrosinated patch. The DDB (dynein-dynactin-BicD2) motile events were higher on 
tyrosinated patches suggesting in the DDB complex, the CAP-Gly of dynactin binds to 
the tyrosinated plus ends ensuring the correct initiation of retrograde transport 
(McKenney et al., 2016). An in vivo evidence of this mechanism of CAP-Gly mediated 
initiation was observed in neurons where tyrosinated patches can be found at the tips of 
the neuritis (Nirschl et al., 2016); and p150’s CAP-Gly domain is essential for initiation 
of vesicle transport in the neuritis (Lloyd et al., 2012; Moughamian and Holzbaur, 2012; 
Nirschl et al., 2016).  
It is not known if similar tubulin modification is also required for Lis1-dependent 
initiation of dynein transport. Furthermore, while Lis1 was shown to be important for 
dynein driven transport of BicD2 positive vesicles in cells, whether, Lis1 acts as an 
initiator of transport of these vesicles was not studied. 
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1.6 Thesis goals 
Regulation of metazoan dynein is complicated and involves several cofactors. The 
ubiquitous regulators of dynein dynactin and Lis1 seem to regulate overlapping dynein 
properties. In vivo both dynactin and Lis1 are essential for almost all dynein driven 
functions including plus end tracking of dynein (Coquelle et al., 2002; Splinter et al., 
2012), and transport of BicD2 positive cargoes (Splinter et al., 2012). While in vivo 
studies have highlighted the essential nature of dynactin and Lis1 regulation, they fail to 
shed light on exactly what aspect of dynein transport requires dynactin and Lis1. In 
vitro reconstitution experiments using purified proteins have proved to be important in 
identifying dynactin and BicD2 as the minimal components of processive dynein 
motion, (McKenney et al., 2014; Schlager et al., 2014) and p150 and EB1 as 
components of dynein’s plus end tracking (Duellberg et al., 2014). However, the 
experimental approaches used for these reconstitution experiments are different.  
The reconstitution of end tracking of metazoan dynein was performed in the presence of 
p150 fragment and EB1 on dynamic microtubules, while the processivity factors—the 
full-length dynactin complex and adaptor protein—were absent in these experiments. 
On the other hand, the reconstitution of processive motion of metazoan dynein in the 
presence of the dynactin complex and adaptor BicD2 was reconstituted on static 
microtubules, which lacked the features of dynamic microtubule, and in the absence of 
EBs, hence no plus end tracking was observed. Therefore, these experiments did not 
provide an understanding of how dynein’s plus end tracking versus processive motion is 
regulated by its key regulators and adaptor proteins. In this thesis, I study the 
simultaneous regulation of the processive behaviour and the plus end tracking of human 
dynein by dynactin, Lis1 and BicD2 in the presence of EBs on dynamic microtubules.  
My specific aims are: 
1. Modulation of processivity of recombinant human dynein 
In this chapter, I report whether nonprocessive behaviour of recombinant human 
dynein arises due to various in experimental conditions such as, heterologous 
expression and design of the dynein constructs. 
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2. Purification of dynactin complex and its functional verification in activating 
dynein motion. 
Here I present a new purification method to purify non-neuronal human 
dynactin from cultured cells and neuronal dynactin from pig brains. Next, I test 
the activity of purified dynactin by reconstituting dynein-dynactin-BicD2 
motion. The purified dynactin complex was used for the in vitro reconstitution 
studies presented in the following section. 
3. Regulation of plus end tracking versus minus end motion of human dynein 
studied on dynamic microtubules 
Using purified proteins, I study the processive motion and plus end localisation 
of the recombinant human dynein complex simultaneously following in vitro 
reconstitution approach and TIRF imaging. I address the following: 
 
i. Reconstitution of processive motion of dynein on dynamic microtubules 
in presence on dynactin and BicD2 
ii. Reconstitution of plus end tracking of dynein-dynactin complex in 
presence of EB1 
iii. Effect of BicD2 on processive dynein motion versus microtubule end 
localisation of dynein                 
iv. Effect of LIS1 on plus end tracking of dynein and initiation of its 
processive motion 
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Chapter 2. Modulation of processivity of 
recombinant human dynein 
2.1 Introduction  
For the long-range transport, dynein moves towards the microtubule minus end at a 
micron scale before detaching from the microtubules. This property is referred to as the 
average run-length or processivity. The first direct evidence of the processive behaviour 
of dynein was observed in a bead assay, where the movement of latex bead coated with 
purified chicken brain dynein was visualised by video-enhanced DIC microscopy 
(Wang et al., 1995). Thereafter, several studies reported the processivity of purified 
dynein from diverse sources ranging from fungi to vertebrate brains (Culver-Hanlon et 
al., 2006; King and Schroer, 2000; Mallik et al., 2005; Toba et al., 2006). Artificial 
dynein dimers from budding yeast (Reck-Peterson et al., 2006) and Dictyostelium 
(Numata et al., 2011) were also reported to exhibit processive behaviour. For budding 
yeast dynein, processivity is achieved due to its increased ratio of microtubule bound to 
unbound time (high duty ratio) of the individual motor domains. Unlike yeast dynein, 
Dictyostelium dynein dimer with a low duty ratio requires coordination between the two 
dynein motor heads for its processivity; this co-ordination is attributed to the C-
sequence.  
However, one of the surprising observations of dynein’s processivity came from 
fluorescence imaging of recombinant human dynein, revealing a lack processivity 
(Trokter et al., 2012). Recombinant human dynein complex (McKenney et al., 2014; 
Schlager et al., 2014; Trokter et al., 2012) and artificially dimerised dynein motor 
fragments (Jha and Surrey, 2015; Nicholas et al., 2015; Torisawa et al., 2014; Trokter et 
al., 2012) showed weak microtubule binding with occasional diffusive or static binding 
episodes. This nonprocessive behaviour of human dynein observed in single molecule 
imaging is in apparent contrast with the processive behaviour of vertebrate dynein seen 
in bead assays and processivity of dynein from lower eukaryotes observed by direct 
fluorescence imaging.  
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At the commencement of the research detailed in this thesis, it was unknown whether 
the difference in processivity between dynein from lower eukaryotes and that from 
vertebrates reflected species-specific differences, or arose from assay-dependent 
variations. To this end, my first aim was to understand the reason behind the lack of 
processivity of recombinant human dynein motor.  
One of the key differences in dynein studied from lower eukaryotes was the expression 
system used for the generation of the dynein constructs. While recombinant budding 
yeast dynein is expressed and purified from budding yeast (Reck-Peterson et al., 2006), 
recombinant human dynein constructs are generated through heterologous expression in 
insect cells (Schlager et al., 2014; Trokter et al., 2012). Therefore, I tested whether the 
lack of processivity of dynein arises due to its heterologous expression in insect cells. 
Furthermore, processivity of artificially dimerised yeast dynein required an intact linker 
domain (Reck-Peterson et al., 2006). Based on this, I tested if varying the length of the 
linker domain of artificially dimerised human dynein could alter its nonprocessive 
behaviour. 
Around the same time, two other reports (Nicholas et al., 2015; Torisawa et al., 2014) 
also studied the molecular properties of dynein that could be responsible for the lack of 
processivity of the artificially dimerised metazoan dynein motor. The C-sequence 
present at the C-terminal end of DHC sequence (Nicholas et al., 2015), and auto 
inhibition of dynein (Torisawa et al., 2014) were subsequently suggested to be the 
reasons behind its nonprocessive behaviour. My experiments and these reports further 
corroborated the observation that metazoan dynein could inherently be nonprocessive. 
In this chapter, to find out whether heterologous expression of dynein in insect cells 
caused the lack of processivity of dynein, I carried out a comparative study of budding 
yeast and human dynein motor fragments expressed and purified from insect cells. Next 
to verify if the truncation of dynein linker domain in artificially dimerised dynein motor 
leads to its nonprocessivity, I studied the dynein motor fragments of different linker 
lengths, by TIRF microscopy. 
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2.2 Results 
2.2.1 Budding yeast dynein expressed in insect cells is a processive 
motor  
To test whether heterologous expression of dynein in insect cells renders it 
nonprocessive, I expressed and purified artificially dimerised budding yeast dynein 
fragment from insect cells. Recombinant human dynein complex and artificially 
dimerised dynein fragments were also generated from insect cells by the same 
purification method. Since the processivity of budding yeast dynein is well established, 
it serves as a good control protein to check the effect of experimental conditions on 
processivity. 
 
 
Figure 2.1 Ensemble activity of yeast dynein expressed in insect cells  
(A) Construct design. An N-terminal His6 tag followed by monomeric GFP (mGFP) (green), the neck 
coiled coil of kinesin-1 (CC, in pink) for dimerisation, and the budding yeast DHC sequence (grey) 
lacking the first 1218 amino acids (i.e. the tail). (B) Schematic representation of a microtubule gliding 
assay on Tris–Ni2+ -nitrilotriacetate(Ni-NTA)–PEG functionalized glass. 100 nM His6 tagged GFP-cc-
yeast Dyn331 motor was immobilized on to Ni-NTA surface, which produce ensemble activity to transport 
Alexa 568 labelled micrtotubules. (C) Histogram of microtubule gliding velocities (fitted with a Gaussian 
function; black line) and a representative total internal reflection fluorescence (TIRF) microscopy 
kymograph of gliding Alexa 568-labelled microtubule are shown. The mean gliding velocity ± s.e.m. was 
57 ±0.8 nm/s). The experiment was performed at 25oC. Image taken from (Jha and Surrey, 2015) 
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The yeast dynein construct (GFP-cc-yeast Dyn331) was similar to the constructs used in 
the previous report (Reck-Peterson et al., 2006) and had DHC sequence without the tail 
domain (i.e. lacking the first 1218 amino acids), the N-terminal His6 tag followed by 
monomeric GFP (mGFP), and the neck coiled-coil of kinesin-1 for dimerisation (Figure 
2.1 A). After purification, the activity of yeast dynein was tested in a microtubule 
gliding assay. In this assay, the His-tagged dynein motors were immobilised on the Ni-
Tris-NTA functionalised glass surface (Figure 2.1 B), allowing oriented attachment of 
motor that transported Alexa 568 microtubules present in solution, by their ensemble 
activity (Figure 2.1 C). The mean gliding velocity for GFP-cc-yeast Dyn331 was 57 nm/s 
(Figure 2.1 C), consistent with previously reported yeast dynein gliding velocities 
(Reck-Peterson et al., 2006). 
 
Figure 2.2 Single molecule imaging of yeast dynein expressed in insect cells  
(A) Schematic representation of a single-molecule imaging assay with Alexa 568- and biotin-labelled 
GMPCPP microtubules immobilized via NeutrAvidin on biotin-PEG functionalized glass. (B) 
Kymograph showing processive runs of budding yeast dimers (100 pM GFP–cc-yeastDyn331 without the 
His6 tag). (C) Histogram of velocities of single budding yeast dynein dimers moving along the Alexa 
568-labelled microtubule (fitted with a Gaussian function; black line). The mean± s.e.m. velocity was 
88± 6.6 nm/s. The run length distribution of single yeast dynein dimer (fitted with mono-exponential 
decay function; black line) is presented. The mean ±s.e.m. run length was 0.7 ±0.04 μm. The temperature 
was always 25◦C. Adapted from (Jha and Surrey, 2015) 
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Having tested the ensemble activity of GFP-cc-yeast Dyn331, I set out to study its motile 
properties at the single molecule level to gain more insight into its processive behaviour. 
For this experiment, the N-terminal His6 tag of GFP-cc-yeast Dyn331 was cleaved off. 
This protein was then imaged at 100 pM concentration on Alexa 568 labelled 
biotinylated GMPCPP microtubules that was immobilised via NeutrAvidin on the 
functionalised biotin glass surface (Figure 2.2 A). GFP-cc-yeast Dyn331, was indeed 
processive, as evident from the kymographs (Figure 2.2 B). Some long static binding 
episodes were also observed, perhaps due to the presence of dead motors, since dead 
motor removal by microtubule sedimentation was not performed in the purification 
procedure. Nonetheless, the mean velocity of moving GFP-cc-yeast Dyn331 was 88 nm/s 
(Figure 2.2 C), and the average run length was 0.7 µm (Figure 2.2D), consistent with 
previously reported measurements (Reck-Peterson et al., 2006). 
 
 
Figure 2.3 Single molecule imaging of recombinant human dynein complex expressed in 
insect cells  
(A) Histogram of microtubule gliding velocities (assay as in Figure 2.1B) and corresponding 
representative kymographs as insets. The mean± s.e.m. was: 0.35±0.07 µm/s. (B) Representative TIRF 
microscopy kymographs of single molecule imaging of recombinant human dynein complex at 100 pM. 
(method as in Figure 2.2A).  
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complex purified from insect cells could transport microtubules in gliding assay, 
consistent with the previously reports (Schlager et al., 2014; Trokter et al., 2012). When 
studied at single molecule level on immobilised GMPCPP microtubules, the 
recombinant human dynein complex showed diffusive and static binding behaviour 
without any detectable unidirectional motion, in agreement with the previous reports 
(Schlager et al., 2014; Trokter et al., 2012). The motile properties of artificially 
dimerised human dynein fragments, similar to GFP-cc-yeast Dyn331, were also studied 
under the same experimental conditions, discussed in the next section. 
These observations indicate that yeast dynein retains its processive behaviour when 
expressed in insect cells, while human dynein produced in the same expression system 
is not processive. 
 
2.2.2 Effect of varying linker lengths on motile properties of artificially 
dimerised human dynein  
Since artificially dimerised human dynein motor (GFP-cc-Dyn380) is generated by 
truncation of DHC (Trokter et al., 2012), it is essential to define a minimal dynein 
motor with the right truncation, which retains most of the motile properties of dynein, 
such as, processivity. For yeast dynein, shortening of linker domain drastically affected 
its motile properties (Reck-Peterson et al., 2006). Based on this, I tested if varying the 
length of the linker domain of GFP-cc-Dyn380 could alter its nonprocessive behaviour. 
GFP-cc-Dyn380 studied previously (Trokter et al., 2012) had the DHC sequence from 
1303 to 4646 amino acids. For this study, two additional constructs were generated by 
truncating DHC at amino acid 1330 and 1267 (Trokter et al., 2012) (Figure 2.4 A). I 
expressed and purified all these artificially dimerised dynein motor fragments from 
insect cells.  Next, I studied the activity of these artificially dimerised dynein fragments 
in microtubule gliding assay. The gliding velocity observed for the three dynein 
fragments were in the range 0.3 to 0.38 µm/s (Figure 2.4 B) comparable to the 
previously reported velocities of mammalian dynein motor (McKenney et al., 2014; 
Schlager et al., 2014; Trokter et al., 2012). Furthermore, at the single molecule level, 
occasional static binding events were observed for all the three artificially dimierised 
dynein fragments (Figure 2.4 C). These results suggest that varying dynein linker length 
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by fifty-four amino acids did not lead to processive behaviour of artificially dimerised 
human dynein. 
 
 
Figure 3.4 Effect of varying linker lengths on motile properties of artificially dimerised 
human dynein  
(A) Construct designs. Three constructs with differently long N-terminal truncations were made, as 
indicated. The DHC amino acid sequence of the three constructs were: (1) 1303-4646 aa (2) 1320-4646 
aa (3) 1276-4646 aa (B) Histogram of microtubule gliding velocities and corresponding representative 
kymographs as insets. The mean± sd. velocities were: 380±7.3 nm/s, 350±9.3 nm/s and 300±13.4 nm/s 
for constructs 1–3 respectively. (C) Representative TIRF microscopy kymographs of single dynein 
dimers at 50 pM concentration of each construct. None of the constructs showed detectable processive 
motility. These results demonstrate that the behavior of artificial human dimers does not depend on the 
exact position of the N-terminal deletions within the range of amino acids 1276–1320. The temperature 
was 25◦C.  
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2.3 Discussion 
In this chapter, I validated that the heterologous expression and the design of the 
artificially dimerised motor constructs, specifically its linker length, did not contribute 
to the apparent lack of processivity of human dynein. Instead, the nonprocessive 
behaviour seems to be an intrinsic property the human dynein motor.  In contrast, yeast 
dynein is a processive motor and retains its processive behaviour when expressed and 
purified from insect cells. Though the structure and sequence of the dynein motor are 
largely conserved between vertebrates and yeast, it is intriguing how its motile 
properties, particularly processivity is dissimilar.  
Part of this difference could be explained by finer structural differences, such as the C-
sequence, which is present at the C-terminal end of the dynein AAA+ ring, and has 
been suggested to be involved in the coordination of motor domains of Dictyostelium 
dynein, crucial for its processive stepping. For budding yeast dynein the c-sequence is 
three times shorter than Dictyostelium and mammalian dynein. Removal of the c-
sequence from rat dynein did impart processivity to the motor (Nicholas et al., 2015). 
Though the mechanism by which the c-sequence could alter dynein’s processive 
behaviour needs further elucidation.  Another study revealed that artificially increasing 
inter-head separation of dynein’s two motor heads by introducing random linker 
sequences resulted in the processive behaviour of artificially dimerised human dynein 
motor (Torisawa et al., 2014). 
 However, processivity achieved through deletion of c-sequence or by artificially 
increasing the motor head separation through artificial linkers does not represent the 
property of physiological dynein motor. Processivity of vertebrate dynein, therefore, 
seems to be a regulated property, activated upon attachment to cellular cargoes and by 
interaction with cargo adaptors and dynactin complex (McKenney et al., 2014; Schlager 
et al., 2014; Urnavicius et al., 2015)
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Chapter 3. Purification of the dynactin complex and 
reconstitution of dynein motion in the presence of 
dynactin and BicD2 
3.1 Introduction  
Initially discovered as an activator of dynein motion (Schroer and Sheetz, 1991a), 
dynactin subsequently was shown to be a ubiquitous regulator of the dynein-driven 
cellular functions (Kardon and Vale, 2009; Schroer, 2004).  For mammalian dynein, 
regulation by dynactin and cargo adaptor, BicD2 was recently shown to be essential for 
reconstitution of its processive motion (McKenney et al., 2014; Schlager et al., 2014; 
Urnavicius et al., 2015). Since the goal of my thesis is to study the regulation of 
multiple aspects of processive human dynein motion, purification of its essential 
regulator—dynactin—is necessary. Specifically, I set out to purify the human dynactin 
complex of matching species with human dynein and human dynein regulators in the in 
vitro reconstitution assays.  
To my knowledge, large-scale purification of human dynactin has not established large-
scale yet. This is possibly due to difficulty in obtaining sources from which large 
amounts of human dynactin could be isolated. Cultured human cells can be used as 
sources of human dynactin. However, due to low abundance of dynactin in these cell 
lines, large amount of starting material is required, making it challenging to apply pre-
existing purification methods (Bingham et al., 1998; Urnavicius et al., 2015). These 
purification methods are designed to isolate dynactin from vertebrate brains (Bingham 
et al., 1998; Urnavicius et al., 2015), which have much higher levels of dynactin. The 
purification steps involve cycling brain lysate through multiple rounds of large-size ion 
exchange columns followed by several hours of sucrose gradient centrifugation. These 
purification steps would be difficult to scale-up2 for enrichment of dynactin from large 
volumes of cell culture.  
 
                                                2	Approximately	1	litre	of	cation	exchange	resin	was	used	for	dynactin	enrichement	from750ml	brain	lysate	(Bingham	et	al.,	1998).	It	will	be	difficult	to	build	similar	columns	to	load	large	volumes	of	cultured	cell	lysates.	
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Further, the purified brain dynactin has distinct subunit isoforms compared to other 
non-neuronal subunit isoforms (Dixit et al., 2008; Zhapparova et al., 2009). Therefore, 
assays with brain dynactin limit our understanding only to neuronal dynactin isoforms. 
In this regard, the purification of dynactin complex from non-neuronal cell lines also 
offers a possibility of observing if tissue specific differences exist in dynactin isoforms 
in the in vitro biochemical assays. Therefore, for my reconstitution experiments, I 
purified non-neuronal dynactin complex from HeLa S3 cell lines, and neuronal dynactin 
from pig brains. 
In this chapter, I present a new two-step method to isolate dynactin from cultured 
human cells and pig brains. In the first step protein (BicD2) affinity matrix is used to 
enrich dynactin from high quantitates of cultured human cells. In the follow-up step 
anion exchange chromatography separates dynactin from non-specific proteins. The 
functional activity of purified dynactin can be studied by reconstituting dynein motion 
in the presence of essential processivity factors—dynactin and BicD2 (McKenney et al., 
2014; Schlager et al., 2014). To this end, I reconstituted recombinant human dynein 
motion in the presence of purified dynactin complex and BicD2 fragment. 
 
3.2 Results 
3.2.1 Purification of dynactin complex 
The first step in developing a purification method from HeLa S3 cells was to estimate 
the amount of starting material needed for isolation of milligram amounts of the 
dynactin complex. By quantitative western blot, using recombinant human p150 as a 
calibrating protein, I estimated that 300 l of HeLa S3 cell culture have 5 milligrams of 
the dynactin complex (Figure 3.1). The previous dynactin purification method 
(Bingham et al., 1998) documented a 25% recovery of initial dynactin pool present in 
brain tissues. Based on this recovery rate, I expected a yield of approximately 1 mg 
from 300 l of starting HeLa S3 cells.  As previously mentioned (in section 3.1), 
enrichment of approximately 4 l of lysates, obtained from HeLa S3 culture will be 
difficult to attain using cation exchange chromatography. Therefore, a new approach 
was adopted to enrich or partially purify dynactin complex from such large volumes of 
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cells using protein affinity chromatography, followed by separation of dynactin from 
dynein and other contaminant proteins by anion exchange (Figure 3.1D).  
 
 
 
Figure 3.1 Estimation of p150 amount in Hela S3 cells 
(A) Quantiative western blotting: Dilutions of (0.1 ng to 0.8 ng) recombinant p1501-517 and dilutions of 
known volume of HeLa S3 cell lysate were resolved in the same gel, followed by western blotting using 
the anti-p150 antibody. The band intensities were measured by band densitometry (intensities of band of 
the respective dilutions are mentioned on the top of the blots). (B) From the band intensities of dilutions 
of the recombinant p150 fragment, a calibration curve was generated. Based on the band density of 16 µl 
HeLa S3 cells the corresponding amount of p150 inferred (shown by the blue line). The red line shows 
the linear fit (R2 = 0.99) (C) Calculation of amount of p150 (dynactin) in HeLa S3 cells based on the band 
intensity value labelled in blue.  
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3.1 D.  Purification protocol overview 
 
 
BicD2400 affinity column preparation 
The dynactin affinity purification method developed in this thesis, takes advantage of 
the interaction between dynein-dynactin complex with BicD2 (McKenney et al., 2014; 
Splinter et al., 2012). Based on this known interaction, I prepared a BicD2400 affinity 
column by conjugating His6 SNAP BicD2400 (Figure 3.2 A and B) to an NHS (N-
hydroxysuccinimide ester–activated Sepharose) column. The method followed for 
conjugating His6 SNAP BicD2400 to NHS matrix (described in the Methods chapter) was 
adapted from previously published technique (Widlund et al., 2012). Estimation of 
bound to unbound fraction of His6 SNAP BicD2400 indicated that at least 45 mg of 
protein conjugated to an NHS column of 5 ml column volume (Figure 3.2 C and D).  
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Figure 3.2 Generation of BicD2400 affinity column 
(A) Molecular diagram of BicD2400. (B) Coomassie stained SDS PAGE of His6-SNAP-BicD2400 was 
expressed and purified from E. coli by one step IMAC purification. (C) Coomassie stained SDS PAGE of 
input material of His6 SNAP-BicD2400 (Input) and unbound protein (Unbound) present in flow through 
after continuous circulation. (D) Input and Unbound lane intensity quantified from the Coomassie stained 
gel shown in C. Based on the intensity ratios, 43% of total protein did not conjugate to NHS column. 
 
Purification of dynein-dynactin using BicD2400 affinity column 
HeLa S3 lysate from a cell pellet of 25 litres of culture was loaded onto one BicD2400 
column. Four such columns were used in parallel for purification from 100 l of Hela S3 
cell culture. After loading, the column was washed extensively.  This wash step 
removed weakly bound non-specific proteins. For final elution, I applied a linear salt 
gradient to resolve the separation of dynactin from other proteins. The elution profile 
revealed two major peaks. The Coomassie-stained gel from the fractions of the first 
peak showed that it was dynein enriched. The fractions of the second peak showed 
intense bands corresponding to the molecular weight of dynein and dynactin subunits 
(Figure 3.3). I collected and pooled the second peak (Figure 3.3A)—the dynein-
dynactin enriched fractions (referred to as BicD2400 column eluate hereafter) for the 
final round of purification.  
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Figure 3.3 BicD2400 affinity column purification from Hela S3 cells 
(A) Elution profile (black curve) of BicD2400 column purification by applying linear NaCl gradient (blue 
line). (B) SDS PAGE Coomassie stained gels of BicD2400 column purification. Elution fractions from 6.5 
ml to 19 ml elution volume were loaded on two separate gels. Molecular weights of the marker loaded are 
labelled on the left-hand side of the gels. The two peaks shown in purification profile are shown on top of 
the two gels. Positions of bands corresponding to dynein’s DHC subunit and dynactin’s p150 subunits are 
shown on the right-hand side of the second gel. Both the gels are from the same purification and were run 
in parallel. 
 
Western blotting of BicD2400 column eluate using antibodies against the p150 subunit of 
dynactin, and the DHC and DIC subunits of dynein confirmed the presence of dynein-
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dynactin in purified fractions (Figure 3.4B). Five dynactin subunits and three dynein 
subunits were also identified by mass-spectrometry (Figure 3.4C). Analysis of band 
intensities corresponding to dynein-dynactin subunits in a Coomassie stained gel 
revealed that 69% of total proteins were subunits of dynein-dynactin complex (Figure 
3.4A). The BicD2400 affinity column generated for this purification was reused for 
multiple rounds of purification by washing the column extensively with high salt 
between each round.  
 
Figure 3.4 Identification of dynein-dynactin subunits in BicD2400 column eluate 
(A) SDS PAGE Coomassie stained gel of BicD2400 column eluate. Bands from this gel were analysed by 
mass-spectrometry. (B) Western blotting of BicD2400 column eluate, using antibodies against dynein’s 
DHC and DIC and dynactin’s p150 subunits. (C) Mass-spectrometry of BicD2400 column eluate showing 
the presence of dynactin and dynein subunits. The percentage of sequence coverage and unique peptide 
picked up by LC/MS for each subunit is tabulated. 
 
Separation of dynein-dynactin by anion exchange chromatography 
The next step of purification involved the separation of dynactin from dynein and other 
non-specific proteins present in BicD2400 column eluate. Due to their similar molecular 
mass, dynein and dynactin cannot be efficiently separated by size exclusion 
chromatography. However, the two complexes do exhibit a difference in their overall 
charge, making the separation by ion exchange chromatography possible. Anion 
exchange chromatography provided a good separation of dynactin from dynein in other 
purification protocols (Bingham et al., 1998; Urnavicius, 2015). Therefore, for my 
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second round of purification, I used Mono Q anion exchange column of 1ml column 
volume (Mono Q column) and eluted dynactin by applying a stepwise salt gradient, 
which was also used in other dynactin purifications (Bingham et al., 1998). BicD2400 
column eluate obtained from 300 l of Hela S3 cell culture was applied to Mono Q 
column. The first major peak at 320 mM NaCl was dynein containing peak (Figure 3.5), 
while dynactin eluted at a higher salt concentration (390 mM NaCl) (Figure 3.5).  A 
total of 0.8 mg of dynactin complex was obtained from 300 l of HeLa S3 cell culture 
and was stored at 0.3 mg/ml concentration frozen in liquid nitrogen.  
 
Figure 3.5 Dynactin purification by anion exchange chromatography  
(A) Anion exchange chromatography using Mono Q 5/50HR column. Elution profile (black profile) 
shows a separation of dynein from dynactin by applying step-wise NaCl gradient (blue). (B) The peak 
fractions and the salt wash step labelled in the profile were loaded onto SDS PAGE gels and stained by 
SYPRO ruby. Bands corresponding to dynein subunits are marked on the right side of the first gel. Bands 
corresponding to dynactin subunits are marked on the right side of second gel.  
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The subunit composition of the purified dynactin was analysed by mass-spectrometry 
(Figure 3.6). All the eleven dynactin subunits were identified, indicating that human 
dynactin purified from Hela S3 cells is a complete dynactin complex (Figure 3.6B).  
Approximately 16% of the initially estimated dynactin amount was recovered from 
HeLa S3 cells using this two-step purification method.  Band densitometry of the 
SYPRO ruby stained gel showed approximately 90% purity of human dynactin complex. 
Using the same method, the calculated molar ratio of subunit stoichiometry of dynactin 
subunit was, 2(p150): 1(p62): 4(p50): 11(Arp1+actin): 2(CapZα): 1(CapZβ): 1(p27): 
2(p24+p25). 
 
 
Figure 3.6 Identification of dynactin subunits by mass-spectrometry  
(A) SDS PAGE Coomassie stained gel of purified human dynactin complex. Bands corresponding to 
dynactin subunits are marked on the right side of second gel. (B) Mass-spectrometry of purified human 
dynactin complex showing the presence of all the dynactin subunits. The percentage of sequence 
coverage and unique peptide picked up by LC/MS for each subunit is tabulated. Except p27 subunit the 
sequence coverage of each the band was above 34% presenting a strong evidence of purification of 
complete dynactin complex.  
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Purification of neuronal dynactin complex from pig brains 
Further, for the comparison of neuronal and non-neuronal dynactin in the in vitro 
reconstitution experiments, I also purified neuronal dynactin from pig brains using the 
BicD2 affinity purification method (Figure 3.7). The clarified lysate (100 ml) from two 
pig brains was then applied to one BicD2400 column (Figure 3.7 A and B). The loading, 
wash and elution from BicD2400 column were done following the same procedure as 
describe for dynactin purification from HeLa S3 cells. The BicD2400 column eluate was 
loaded on the MonoQ column for separation of dynactin from other proteins. Stepwise 
salt gradient was applied to isolate dynactin (Figure 3.7.C). Approximately a total of 0.2 
mg of dynactin was obtained from two pig brains and was stored at 0.2 mg/ml frozen in 
liquid nitrogen. Thus, the purification method described in this chapter can be used to 
purify neuronal and non-neuronal dynactin from brain tissues and cultured mammalian 
cells. 
 
 
Figure 3.7 Purification of neuronal dynactin complex from pig brains 
(A) Elution profile (black curve) of BicD2400 column purification of pig brain dynactin by applying linear 
NaCl gradient (blue line). (B) SDS PAGE Coomassie stained gel of BicD2400 column purification. Elution 
fractions from 4 ml to 17 ml elution volume were loaded on gel. Molecular weights of the marker loaded 
are labelled on the right side of the gels. The positions of bands corresponding to dynein’s DHC subunit 
and dynactin’s p150 and p135 subunits are shown on the left side of the gel. The fractions pooled and 
processed in the next round is indicated on top of the gel. 
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Figure 3.7 Purification of neuronal dynactin complex from pig brain  
(C) Anion exchange chromatography using Mono Q 5/50HR column. Elution profile (black profile) 
shows a separation of dynein from dynactin by applying step-wise NaCl gradient (blue). (D) The peak 
fractions and the salt wash step labelled in the profile was loaded onto SDS PAGE gel and stained by 
Coomassie. Bands corresponding to dynein subunits are marked on the right side of the first gel. Bands 
corresponding to dynactin subunits are marked on the right side of second gel. Both the gels are from the 
same purification and were run in parallel. 
 
3.2.2 Functional test of purified dynactin complex: reconstitution of 
dynein-dynactin-BicD2 motion. 
The recent in vitro reconstitution of processive vertebrate dynein motion using dynactin 
and cargo adaptors offers a direct assay to test the activity of purified dynactin 
(McKenney et al., 2014; Schlager et al., 2014). The attachment of full-length dynactin 
complex to mammalian dynein via cargo adaptor BicD2400 was essential for processive 
dynein motion. Therefore, to test the activity of purified dynactin complex, I studied the 
processive motion of GFP recombinant human dynein in the presence of purified human 
dynactin complex and recombinant BicD2400 fragment on GMPCPP stabilised 
microtubules, by TIRF imaging (Figure 3.8 A).  
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Figure 3.8 Reconstitution of DDB motion on stabilised microtubules 
(A) Schematic overview of a TIRF imaging. 1 nM GFP tagged recombinant human dynein, 2 nM purified 
human dynactin complex, and recombinant 20 nM BicD2400 (DDB) is studied on Alexa 568 labelled 
biotinylated GMPCPP stabilised microtubules immobilized via NeutrAvidin on biotin-PEG 
functionalized glass Imaged at 25oC. (B) Kymographs showing DDB events. (C) Kymographs showing 
diffusive or static binding dynein events when dynactin is absent. (D) Kymographs showing diffusive or 
static binding events when in the absence of BicD2400. (E) Run length distribution of processive DDB. 
The average run length ± s.e.m was 4.47± 0.23 µm (n =159 complexes). (F) Histogram of velocity 
distribution. The mean velocity ± s.e.m 406.36 ±19.30 nm/s (n=233 segments) 
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Consistent with previous findings (McKenney et al., 2014; Schlager et al., 2014), 
processive GFP dynein motion was observed only in the presence of purified dynactin 
complex and BicD2400 (Figure 3.8.B). Removal of purified dynactin complex (Figure 
3.8.C) or BicD2400 (Figure 3.8.D) from this assay resulted in diffusive or static binding 
of GFP dynein, highlighting the crucial role of dynactin as a processivity factor. Three 
types of behaviour were observed for DDB in this assay, static binding, diffusion, and 
processive motion (for analysis see Methods). For processively moving DDB 
complexes, run lengths and velocities were measured and plotted as a histogram. The 
average velocity of moving DDB was 406.36 nm/s, and the mean run length was 4.5 µm 
agreeing with the ultra processive behaviour of DDB complex reported in earlier 
studies(McKenney et al., 2014; Schlager et al., 2014). 
To conclude, full-length dynactin complex could be successfully purified from cultured 
mammalian cells and pig brains by BicD2 affinity purification method. The addition of 
the purified human dynactin, together with BicD2400, resulted in processivity of GFP-
tagged human dynein, indicating that purified dynactin is functionally active. 
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3.3 Discussion  
In this chapter, I presented a new method of purification of dynactin complex from 
HeLa S3 cells and pig brains. This is the first large-scale purification of non-neuronal 
human dynactin complex. Due to low abundance of dynactin in non-neuronal cells, a 
high amount of staring material was required. Using BicD2 protein affinity matrix, 
dynactin from large volumes of starting material, which would be difficult to process 
following previously described techniques (Bingham et al., 1998; Urnavicius, 2015). In 
this method, the recovery of dynactin (16%) was lower than the recovery reported for 
published methods (25%). However, compared to another protein-affinity based 
dynactin purification, such as microtubule affinity purification, with 2% recovery 
(Bingham et al., 1998), this method provides a much higher recovery. Furthermore, 
purification of dynactin from cultured cells by microtubule affinity would require large 
amounts of purified tubulin, which cannot be reused. 
The BicD2 affinity purification method also offers a faster and less labour-intensive 
purification of brain dynactin compared to the previous protocols.  Further, a single 
BicD2400 affinity column is used for multiple rounds of purifications, since BicD2400 is 
covalently conjugated to the NHS resin, providing a long-lasting reusable purification 
matrix unlike microtubule affinity purification method. For the affinity purification of 
dynactin, I tested only BicD2400 fragment as affinity matrix for dynactin enrichment, 
however, in the future other dynactin interactors could be tested to try to further 
improve the yield of the affinity purification step. 
Another advantage of developing a purification of dynactin from cultured cells is that it 
offers a system to genetically manipulate dynactin complex. In the future, using this 
method fluorescent dynactin complex can be generated from cell lines overexpressing a 
fluorescently tagged dynactin subunit. By tagging p62 subunit of dynactin in human cell 
line (McKenney et al., 2014) fluorescently labelled dynactin complex was co-purified 
with dynein and BicD2 complex in small quantities. The method presented in this 
chapter could be used to purify fluorescent dynactin from similar sources in large 
quantities.  
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Chapter 4. Regulation of processive motion and 
microtubule plus-end    localisation of dynein 
4.1 Introduction  
Although dynein is a minus end directed motor, it also localises to the plus ends of 
microtubules (Kardon and Vale, 2009; Splinter et al., 2012; Zhang et al., 2003). The 
dynamic plus ends of microtubules are thought to serve as sites for cargo loading 
(Vaughan et al., 2002) and initiation of minus end directed dynein transport (Lloyd et 
al., 2012; Moughamian and Holzbaur, 2012). The key dynein regulators—dynactin and 
Lis1—appear to play a crucial role in both recruitment of dynein to plus ends and 
regulation of its minus end motion (Kardon and Vale, 2009; Splinter et al., 2012). 
However, the extent to which these two regulators control dynein’s plus end recruitment 
versus its minus end motion remains unclear (Splinter et al., 2012). In this chapter, I 
investigate the role of human dynein regulators in controlling processive motion versus 
plus-end tracking of dynein on dynamic microtubules.  
Metazoan dynein is recruited to microtubule plus ends through its interaction with the 
microtubule plus-end binding proteins (+TIPs)—dynactin and EBs (Duellberg et al., 
2014; Moughamian and Holzbaur, 2012). For this pathway, the largest dynactin subunit 
p150, forms the hub of interaction sites, mediating interactions with EBs via its CAP-
Gly domain (Moughamian and Holzbaur, 2012; Vaughan et al., 2002), and with the 
dynein intermediate chain via its CC1 domain (King and Schroer, 2000; Schroer, 2004; 
Vaughan and Vallee, 1995). Extensive in vitro characterisation of both neuronal and 
non-neuronal p150 fragments have provided information about its interaction with other 
+TIPs (Duellberg et al., 2014), its role as an anti-catastrophe factor and a microtubule 
nucleator (Lazarus et al., 2013). However, in vitro evidence of the plus-end tracking 
behaviour of the full-length dynactin complex or the dynein-dynactin complex is 
lacking. This is important to study, given the recent structural findings of the full-length 
dynactin complex, where the p150 subunit possibly assumes a folded/auto-inhibited 
conformation and has a weak binding to dynein and microtubules (Chowdhury et al., 
2015; Urnavicius et al., 2015). It is unknown if in this conformation the dynactin 
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complex can recruit dynein to the microtubule plus ends, or whether additional 
cofactors are required to promote the dynein-dynactin-EB interaction at plus ends. 
While in vitro, the p150-dependent plus end tracking of vertebrate dynein can persist in 
the absence of Lis1 (Duellberg et al., 2014), it is intriguing why both dynactin and Lis1 
are involved in dynein’s plus end targeting in non-neuronal cultured cells (Coquelle et 
al., 2002; Splinter et al., 2012). More generally, how dynactin and Lis1 may function 
together to target dynein to the plus ends remains unclear. Lis1 was shown to facilitate 
the dynein-dynactin interaction during mRNA transport in Drosophila extract (Dix et al., 
2013) and for spindle formation in Xenopus egg extract (Wang et al., 2013), indicating a 
combinatorial role of dynactin and Lis1 in dynein regulation. For a processive yeast 
dynein, Lis1 biases its plus-end localisation by impeding the minus-end directed dynein 
motion (Roberts et al., 2014; Sheeman et al., 2003). For a non-processive metazoan 
dynein the inhibition of minus-motion was not required in the plus end tracking 
experiments. Lis1 could conceivably be important for metazoan dynein’s plus-end 
tracking in cells where dynein processivity is activated by dynactin and BicD2  
(Coquelle et al., 2002; Splinter et al., 2012). Direct evidence of such a combinatorial 
regulation of dynein’s microtubule localisation is lacking.  
Both in cells and in vitro, the dynactin(or p150)—dependent plus-end association of 
dynein does not require additional stabilisation of their interaction by adaptor protein 
BicD2 (Splinter et al., 2012; Duellberg et al., 2014). On the contrary, expression of the 
BicD2400 fragment in mammalian cell lines abolished dynein localisation at the 
microtubule tips (Splinter et al., 2012).  Similarly, in budding yeast, expression of a 
fragment of Num1 adaptor protein led to the removal of dynein-dynactin from the plus 
ends (Lammers and Markus, 2015). These observations point to a unique ‘switch like’ 
function of adaptor proteins, where they appear to remove dynein’s plus-end 
localisation by activating the dynein–dynactin motion away from the plus ends. 
Although this potential switching mechanism of adaptor proteins has not been probed 
directly.  
Another important function of dynein regulators at the microtubule plus ends is to 
initiate dynein transport. Deletion of the CAP-Gly domain of p150 caused a significant 
reduction of initiation of retrograde transport of LAMP1 and Rab5 positive vesicles in 
distal neuritis, while the transport along the axonal length was unaffected. (Lloyd et al., 
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2012; Moughamian and Holzbaur, 2012). Instead, Lis1 seems to be crucial for initiation 
of dynein transport along the entire length of axonal microtubules (Moughamian et al., 
2013). Lis1-dependent initiation of dynein transport was also observed for dynein in 
filamentous fungi (Egan et al., 2012; Lenz et al., 2006). It is unclear whether Lis1 
and/or dynactin based initiation operates only for a subset of dynein cargos or is a 
general mechanism of initiation of dynein-driven transport.  
What is the molecular mechanism by which dynein regulators control dynein’s plus end 
localisation versus its processive minus end motion on dynamic microtubules? How is 
dynein motion initiated at the microtubule plus ends? To address these questions, I 
study the regulation of the recombinant human dynein complex by dynactin, EBs, Lis1 
and BicD2 on dynamic microtubules following an in vitro reconstitution approach.  
This allows simultaneous investigation of human dynein motility and microtubule plus 
end tracking in the same assay. First, I reconstituted and characterised processive 
motion of recombinant human dynein on dynamic microtubules.  Next, using the 
purified dynactin complex and EBs, I studied the plus end tracking behaviour of dynein 
in a dynamic microtubule assay. Finally, I investigated the combined effect of dynactin, 
BicD2 and Lis1 on the plus end localisation of dynein and in the initiation of its motion. 
 
 
 
 
4.2 Results 
4.2.1 Reconstitution of DDB motion on dynamic microtubules 
In vitro studies of the motile properties of vertebrate dynein have only been performed 
on stabilised microtubules (McKenney et al., 2014; Schlager et al., 2014; Trokter et al., 
2012). In cells, however, dynein transport occurs on the dynamic microtubule filaments, 
which can influence dynein’s microtubule localisation and its motile behaviour. To 
characterise the motile properties of dynein on these constantly growing and shrinking 
tracks, I reconstituted the motion of recombinant human dynein, in the presence of 
dynactin and BicD2 (DDB) in a dynamic microtubule assay. The experimental 
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conditions used to study DDB motion on static microtubules were not compatible with 
the dynamic microtubule assay conditions. First, while DDB motion on static 
microtubules requires one type of nucleotide (ATP), studying DDB motion on dynamic 
microtubules required two types of nucleotides: GTP for microtubule dynamics and 
ATP for powering DDB motion. Second, the DDB motion on static microtubules has 
been studied at 25oC, whereas the dynamic microtubule assay is generally performed at 
30oC (suitable for microtubule growth). The microtubule lattice of dynamic 
microtubules was also different from the stabilised GMPCPP microtubule tracks used 
for DDB motion in the previous studies Therefore the first step was to establish the 
right buffer and imaging conditions that allowed both microtubule growth and DDB 
motion. 
In the presence of 17.5 µM tubulin (with 10% Alexa 568 labelled tubulin), microtubules 
were grown from the immobilised Alexa 568 labelled GMPCPP stabilised short 
microtubule stretches (GMPCPP seeds) (Figure 4.1A). These growing microtubules 
served as dynamic tracks for DDB motion. Two-colour TIRF imaging of GFP-tagged 
dynein and Alexa 568 labelled tubulin allowed simultaneous visualisation of the DDB 
motion and microtubule growth (Figure 4.1 B and C). 
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                        A.  
 
                       
                                                  B.                                                              C.                                 
 
Figure 4.1 Reconstitution of Dynein motion on dynamic microtubule 
(A) Schematic overview of TIRF imaging. GFP-dynein-dynactin-BicD2400 complexes (DDB) were 
imaged on Alexa 568 microtubule growing from immobilized biotinylated Alexa 568 GMPCPP 
microtubule seed. GMPCPP seeds were immobilized by adding NeutrAvidin on biotin-PEG 
functionalised glass surface (modified from Bieling et al. 2010b). The experiment was performed at 30oC. 
Images were acquired at 100 ms exposure in 488 nm channel and 561 nm channel, and 500 frames were 
acquired at a frame rate of 1 fps. (B) TIRF Imaging snapshot at 250 s time interval showing dynamic 
microtubule growth from GMPCPP seeds (red) and GFP dynein (green) binding to dynamic microtubules 
in the presence of untagged BicD2N400 and purified dynactin complex. (C) Representative kymograph of 
dynamic microtubule (MT) (red) with the fast growing plus-end and the slow growing minus-end (shown 
as ‘+’ and ‘–’ respectively on top of kymograph) and GFP dynein (green) processive motion towards the 
minus-end of microtubule. 
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As reported by others (McKenney et al., 2014; Schlager et al., 2014) and in the previous 
chapter of this thesis, processive dynein motion was achieved only in the presence of 
purified dynactin complex and BicD2400 fragment. I analysed GFP dynein events by 
semi-automated analysis of kymographs using KymographDirect, where unidirectional 
events and the diffusive and static trajectories present in single kymographs are Fourier 
filtered followed by automated analysis (Mangeol et al., 2016) (see Methods for 
analysis procedure). GFP dynein showed three major types of events on dynamic 
microtubules – static binding, diffusion, and processive motion (Figure 4.2A). The fast 
growing nature of the dynamic microtubule plus ends and slow growing minus ends in 
this assay helped in clear identification of the microtubule polarity and the directionality 
of DDB events. The unidirectional motions were directed towards the slow growing 
minus ends of the dynamic microtubules. The velocity of each moving segment was 
plotted as a histogram (Figure 4.2B). The mean velocity was 0.34 µm/s. The average 
run length of processive DDB was 4.1 µm (Figure 4.2C). These measurements agree 
with the previously published data of DDB motion on static microtubules (McKenney et 
al., 2014; Schlager et al., 2014) (Table 4.1). 
 
Table 4.1 Motile properties of mammalian DDB reported in the in vitro studies 
 
 
 
 
Method 
Velocity 
(µm/s) 
Run length 
(µm) 
Reference 
Fluorescence 
microscopy 
 
0.40–0.50 
 
5.0–9.0 
 
 (McKenney et al., 2014) 
Fluorescence 
microscopy 
 
0.38 
 
8.5 
 
(Schlager et al., 2014) 
 
Bead assay 
 
0.51 
 
- 
 
(Belyy et al., 2016) 
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C. 
 
Figure 4.2 DDB motion on dynamic microtubule 
(A) Kymographs: showing dynamic microtubules (first column and red in merge shown in third column) 
imaged in 561 nm channel and GFP dynein events (second column and green in merge shown in third 
column) in the presence of untagged purified human dynactin complex and BicD2400. Motile behaviour of 
10 nM GFP dynein (green) was studied in the presence of 20 nM of human dynactin and 200 nM 
BicD2400 on dynamic microtubule (red) grown from Alexa 568 GMPCPP seeds (17.5 µM tubulin). The 
experiment was performed at 30oC. Image was acquired at 100 ms exposure in 488 nm and 561 nm 
channel, and 500 frames were acquired at a frame rate of 1 fps. (B) Velocity distribution: Histogram of 
velocities of processively moving DDB. Mean± s.e.m = 0.34 ± 0.02 µm/s (n=366) (C) Run length 
distribution: Mean± s.e.m = 4.1 ± 0.13 µm (n=326) 
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To find out whether BicD2400 attached to dynein during its processive run, I used 
fluorescently labelled BicD2400 protein to visualise its colocalisation with the GFP 
dynein on dynamic microtubules (Figure 4.3A). To generate fluorescent BicD2400, I 
expressed and purified an N-terminal SNAP-tagged BicD2400, which was labelled with 
Alexa 647 to generate SNAPAlexa647 BicD2400. More than two-thirds of the moving GFP 
dynein contained SNAPAlexa647 BicD2400 (Figure 4.3B). Quantification of the BicD2 
colocalisation with moving dynein was not done in previous studies (McKenney et al., 
2014; Schlager et al., 2014), though it was reported that not all moving DDB complexes 
contained both the labelled components, perhaps due to photo-bleaching (McKenney et 
al., 2014). I observed that very few diffusive and static binding episodes of GFP dynein 
had SNAPAlexa 647BicD2400 signals (Figure 4.3 B) indicating BicD2400 primarily attached 
to the moving dynein-dynactin and is needed for the processive dynein motion.   
In conclusion, these experiments provide the first in vitro reconstitution of the 
processive metazoan dynein motion on dynamic microtubules. The observed average 
velocity and run-length of moving DDB complex on dynamic microtubules agreed with 
those reported for DDB motion on stabilised microtubules (McKenney et al., 2014; 
Schlager et al., 2014), despite the variations in assay conditions of the two 
reconstitutions.  
 
 
 
 
Chapter 4 Results 
 74 
 
 
Figure 4.3 Three-colour imaging of DDB events on dynamic microtubules 
(A) Kymographs: Motile behaviour of 10 nM GFP dynein (second column and green in merge) was 
studied in the presence of 20 nM human dynactin and 200 nM SNAPAlexa 647 BicD2400 (second column and 
magenta in merge) on Alexa 568 dynamic MT (first column). The experiment was performed at 30oC. 
Images were acquired at 100 ms exposure simultaneously in 488 nm and 640 nm channels and alternating 
in 561 nm channel, and 500 frames were acquired at a frame rate of 1 fps. (B) Types of DDB events: 
Number of processive moving, diffusing and static DDB events were quantified by counting GFP Dynein 
events (light grey columns) and percentage of events with both GFP Dynein and SNAPAlexa 647 BicD2400  
colocalisiation (dark grey columns). 
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4.2.2 Microtubule plus end localisation of dynein in the presence of 
dynactin complex  
In cells, both dynein and the dynactin complex robustly track the microtubule plus ends 
(Moughamian et al., 2013; Splinter et al., 2012). However, in vitro evidence of plus end 
tracking of the dynein-dynactin complex is lacking. The previous in vitro reconstitution 
used a p150 fragment consisting of N-terminal 1-517 (p1501-517) and EB1 as the minimal 
components necessary for plus end tracking of recombinant human dynein.  It is 
unknown whether comparable to p1501-517, the full-length dynactin complex (because of 
its proposed inhibited state) can interact with EB1 and human dynein at the microtubule 
plus ends, or whether additional cofactors are required. To understand this, I 
reconstituted the plus-end tracking of GFP labelled recombinant human dynein in the 
presence of the purified dynactin complex and EB1 in a dynamic microtubule assay 
(Figure 4.4 A and B).  
In the presence of the human dynactin complex and EB1, the GFP dynein was observed 
to localise to the dynamic microtubule plus ends (Figure 4.4 C and D and Figure 4.5A). 
Upon removal of either EB1 or dynactin from this assay (Figure 4.5 B and C), the plus-
end localisation of dynein was abolished, substantiating that EB1 and dynactin are 
essential for the dynein end-tracking pathway. Interestingly, I also observed dynein 
signal at the shrinking or depolymerising plus ends (Figure 4.4 C and D). Interaction of 
dynein with the shrinking plus ends has been previously reported for a yeast dynein 
motor fragment in the absence of +TIP regulators (Laan et al., 2012). However, the 
precise molecular mechanism of shrinking end localisation of dynein is not well 
understood. Whether the dynactin complex is present together with dynein at 
depolymerising microtubule plus ends is yet to be studied. 
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Figure 4.4 Reconstitution of plus end localisation of GFP dynein 
(A) Experimental Overview of dynamic microtubule assay. Plus-end tracking behavior of GFP Dynein 
was studied in the presence of purified dynactin and EB1/3 on Alexa 568 labelled dynamic microtubules 
grown from immobilized Alexa 568 GMPCPP seed. The experiment was performed at 30oC (modified 
from Bieling et al. 2010b). Image was acquired at 100 ms exposure in 488 nm and in 561 nm channel, 
and 500 frames were acquired at a frame rate of 1fps (B) TIRF imaging snapshot at three different time 
points during image acquisition showing dynamic microtubule growth from GMPCPP seeds (red) in the 
presence of 17.5 µM tubulin with 10% Alexa 568 tubulin and 10 nM GFP dynein (green) binding to plus 
ends of dynamic microtubules in the presence of untagged 20 nM human EB1 and 10 nM purified human 
dynactin complex. (C) Time series of TIRF microscopy images 20 nM GFP Dynein localising to growing 
(white arrows) and shrinking (grey arrows) microtubule plus ends in the presence of 20 nM human 
dynactin complex and 30 nM EB1. (D) Kymograph: Representative kymograph (of same microtubule 
shown in Time series A) showing GFP dynein (green) tracking plus ends in the presence of human 
dynactin and EB1. Image was acquired at 200 ms exposure in 488 nm and 561 nm channel, and 500 
frames were acquired at a frame rate of 1fps. Temperature was 30oC. 
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Figure 4.5 Two-colour imaging of plus-end tracking of GFP Dynein  
(A) Kymographs of plus-end tracking behaviour of 10 nM GFP Dynein in presence of 20 nM human 
dynactin and 20 nM EB1. (B) Kymographs showing loss of end tracking behaviour of 10 nM GFP 
Dynein with 20 nM human dynactin in the absence of EB1. (C) Kymograph showing loss of end tracking 
of 10 nM GFP Dynein with 20 nM EB1 in the absence of purified dynactin. Image was acquired at 200 
ms exposure in 488 nm and 561 nm channel, and 500 frames were acquired at a frame rate of 1 fps. The 
experiments were performed at 30oC.  
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mentioned in Chapter 2, the neuronal dynactin complex was purified from pig brains, 
and the non-neuronal human dynactin complex was purified from HeLa S3 cells. I 
compared the GFP dynein intensities in the end tracking experiments done in the 
presence of 10 nM of pig brain dynactin and EB1 versus 10 nM purified human 
dynactin and EB1 (Figure 4.6 A). To quantify the fluorescence intensity of dynein at 
plus ends, averaged GFP dynein intensities were measured from kymographs: each 
kymograph was straightened and centred using the previously marked microtubule end 
positions. All kymographs from one data set were aligned and averaged. The 
fluorescence intensities were then averaged for all time points at each position along the 
resulting kymographs, to generate time-averaged spatial intensity profiles. The GFP 
dynein intensity measured at the plus ends showed no significant difference in the end 
tracking experiment with the neuronal and non-neuronal dynactin (Figure 4.6 B), 
indicating that dynactin from both the sources are equally efficient at least in recruiting 
dynein to the microtubule plus ends.  
 
                                         A.                                                B. 
                                                
Figure 4.6 Comparison of GFP Dynein plus-end tracking in the presence neuronal and 
non-neuronal dynactin 
(A) Kymograph showing end tracking behaviour of 10 nM GFP Dynein in the presence of 10 nM 
neuronal dynactin purified from pig brains, and 20 nM EB1. (B) Kymograph showing plus-end tracking 
behaviour of 10 nM GFP Dynein in the presence of 10 nM non-neuronal human dynactin purified from 
HeLa S3 cells, and 20 nM EB1. 
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Figure 4.6. C Plot showing averaged GFP dynein intensity distribution at microtubule plus 
ends.  
The averaged GFP Dynein intensities at the microtubule plus-end region were measured at microtubule 
plus ends for each condition and background-subtracted intensities were plotted against distance from 
microtubule plus ends. The profile shows mean GFP intensity from three different experiments. The error 
bars are the standard deviations. * P value (by the two-tailed t-test) equals 0.0522, this difference is not 
statistically significant. 
 
 
Does the dynactin-dependent plus end localisation of dynein require its ATP-dependent 
motor activity? To address this, I carried out GFP dynein end-tracking experiment in the 
absence of ATP. ATP present in GFP dynein and purified dynactin protein storage 
buffer was removed by desalting these proteins to a buffer without ATP. GFP dynein 
tracked plus ends in the absence of ATP (Figure 4.7), suggesting the ATP-dependent 
motor activity of dynein is not required for the end tracking. It is conceivable that for 
plus end tracking, dynein hitchhikes its regulators to bind to the microtubules without 
requiring its ATP dependent activity. In the absence of ATP, overall microtubule 
recruitment of dynein was high. This is possibly due to the enzymatic cycle of dynein 
where high microtubule binding in the absence of consistent with the previous reports 
(Gibbons et al., 2005; Roberts et al., 2013; Trokter et al., 2012). 
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Figure 4.7 Plus-end tracking of GFP dynein in absence of ATP 
Kymographs showing 10 nM GFP Dynein at microtubule plus-ends, in the presence of 10 nM human 
dynactin and 20 nM EB1, in the absence of ATP buffer.  Image was acquired at 100 ms exposure 
simultaneously in 488 nm and 640 nm channels and alternating in 561 nm channel, and 500 frames were 
acquired at a frame rate of 1 fps. The experiment was performed at 30oC 
 
The important role of EBs for the plus end tracking of vertebrate dynein is well 
established, however direct in vitro visualisation of EB and dynein colocalisation on 
microtubule plus ends has not been performed so far. To generate labelled EB for this 
experiment, SNAP tagged EB3 was purified from E. coli and labelled with Alexa 647-
SNAP dye to generate SNAPAlexa 647EB3. Using a three-colour TIRF microscopy, GFP 
dynein and SNAPAlexa 647EB3 were observed to colocalise at plus ends of Alexa 568 
dynamic microtubules in the presence of the purified pig dynactin complex (Figure 4.8). 
This experiment provides the first in vitro evidence of direct colocalisation EB3 and 
dynein at microtubule ends, and confirms the EB3 dependent plus end tracking of 
dynein. 
 
5 µm
120 s
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Figure 4.8 Three-colour imaging of plus end tracking of GFP Dynein  
Kymographs showing GFP Dynein (third column of kymograph and green in merged kymograph) 
colocalisation with EB3-SNAPAlexa647 (second column of kymograph and red in merged kymograph), in 
the presence of pig dynactin, on Alexa 568 dynamic microtubule (first column and blue in merged 
kymograph). The protein concentrations were: 10 nM GFP dynein, 10 nM pig dynactin and 20 nM EB3. 
Image was acquired at 200 ms exposure simultaneously in 488 and 640 channels and alternating in 561 
channel, and 500 frames were acquired at a frame rate of 1fps. The experiment was performed at 30oC. 
The scale bar in x axis was 5 µm and in y axis was 120 s. 
 
Next, I studied the impact of dynein-dynactin complex on microtubule growth velocity. 
I measured the growth velocities at 17.5 µM tubulin concentration, in the presence of 10 
nM EB3 alone and in the presence of 10 nM each of dynein, dynactin and EB3. The 
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mean growth velocity increased 1.5 times upon addition of dynein-dynactin (Figure 4.9). 
This increase in growth velocity agrees with the previously reported microtubule 
polymerase role of dynactin’s p150 fragment (Lazarus et al., 2013). Whether the 
increased microtubule growth velocity is because of the microtubule binding of p150 
via the CAP-Gly domain or because of modulation of microtubule growth by other 
subunits of dynein and dynactin remains to be studied.  
 
 
Figure 4.9 Microtubule growth velocity measurements  
Microtubule growth velocities: Microtubule growth velocity in the presence of 10 nM EB3 and in the 
presence of 10 nM each of GFP Dynein, dynactin, EB3. The experiment was performed at 30oC. *The 
two-tailed P value equals 0.0067 (the difference in growth velocities is statistically significant).  
 
This is the first reconstitution of plus end tracking of metazoan dynein in the presence 
full-length dynactin complex and EB1. These findings show that human dynein can 
track growing and shrinking microtubule plus ends in the presence of purified neuronal 
as well as non-neuronal dynactin and EBs. The ATP-dependent motor activity is not 
required for the end tracking behaviour of human dynein. Further, dynein-dynactin 
caused an increase in microtubule growth velocity. A detailed analysis of regulation of 
microtubule dynamics by dynein and dynactin complex is required.  
 
EB3 Dynein-Dynactin-EB3
0
5
10
15
20
25
G
ro
w
th
 v
el
oc
ity
 (n
m
/s
)
[Tubulin] =17.5µM
* 
* 
Chapter 4 Results 
 83 
4.2.3 BicD2400 removes dynein from microtubule plus ends 
Recent in vitro reconstitution experiments (McKenney et al., 2014; Schlager et al., 
2014) have highlighted the important role of BicD2400 fragment in processive minus end 
directed dynein motion on stabilised microtubules. In cultured cells, however, 
expression of this BicD2400 fragment led to removal of dynein from dynamic 
microtubule ends (Splinter et al., 2012). To test whether BicD2400 directly acts as an 
inhibitor of plus end tracking behaviour of dynein, I introduced the purified BicD2400 
fragment to the dynein-dynactin end-tracking assay.  
 
Figure 4.10 Kymograph showing DDB not present at plus ends 
Kymographs showing 10 nM of GFP Dynein (second column of kymographs) tracking dynamic 
microtubule plus ends (first column of kymographs) in presence of 10 nM pig dynactin, 10 nM EB1, and 
200 nM SNAPAlexa 647BicD2400 (third column of kymographs). Image was acquired at 100 ms exposure 
simultaneously in 488 nm and 640 nm channels and alternating in 561 nm channel, and 500 frames were 
acquired at a frame rate of 1 fps. SNAPAlexa 647BicD2400 did not colocalise with GFP dynein at microtubule 
plus ends but it was present with motile GFP dynein as a part of DDB complex. Temperature was 30oC. 
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First, I added 200 nM BicD2400 to the GFP dynein end-tracking assay done in the 
presence of dynactin and EB1. At this concentration, I observed both plus end tracking 
and processive motion of GFP dynein. Simultaneous imaging of SNAPAlexa 647 BicD2400 
revealed that the BicD2 signal colocalised with the moving GFP dynein while no 
colocalisation was observed between BicD2400 and GFP dynein at microtubule plus ends 
(Figure 4.10). This suggests that free BicD2400 alone as well as the BicD2400 bound 
dynein-dynactin (DDB complex) do not track plus ends of dynamic microtubules. Since 
the DDB complex does not appear to localise at plus ends, it is possible that attachment 
of BicD2400 biases the plus end localisation behaviour of dynein. To this end, I tested 
whether increasing BicD2 concentration in the end tracking assay further reduced the 
plus end localisation of dynein. 
I attempted to outcompete the plus end tracking behaviour of GFP dynein by adding 
twenty-five times higher amount (5 µM) of BicD2400 compared to the BicD2400 
concentration in the previous assay (Figure 4.10). For this experiment, untagged 
BicD2400 was used, since it could be purified in higher quantities compared to 
SNAPAlexa647BicD2400. At high BicD2400 concentration, the plus end localisation of GFP 
dynein decreased starkly (Figure 4.11B) compared to its plus end accumulation seen in 
the absence of BicD2400 (Figure 4.11A). The plot of averaged plus end intensity of GFP 
dynein showed diminished dynein intensity in presence of 5 µM BicD2400 compared to 
GFP dynein intensity in the absence of BicD2400 (Figure 4.11). This observation 
strongly indicates that BicD2400 can deplete GFP dynein pool at microtubule plus ends 
and activate its processive minus end motion away from plus ends (Figure 4.11B).  
To summarise, the dynein-dynactin-BicD2 complex did not localise to the plus ends of 
microtubules in the end tracking experiments presented in this section. Moreover, at 
high BicD2400 concentration the plus end localisation of dynein was starkly diminished 
(Figure 4.11), thereby acting as an inhibitor of the dynactin-dependent plus end tracking 
of dynein.  
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Figure 4.11 Effect of BicD2400 on plus end tracking behaviour of GFP Dynein 
(A) Kymograph: 10 nM GFP Dynein (green) seen at plus ends of Alexa 568 dynamic microtubules (red) 
in the presence of 20 nM purified pig dynactin and 20 nM EB1. Images were acquired at 200 ms 
exposure 488 nm and 561 nm channel, and 500 frames were acquired at a frame rate of 1 fps. The 
temperature was 30oC. (B) When 5 µM of untagged BicD2400 is added to the same GFP Dynein end 
tracking experimental conditions, the plus end tracking is diminished and processive runs were observed. 
(C) Averaged GFP Dynein intensity distributions at plus ends in the presence of 5 µM BicD2400 (red 
curve) is reduced by more than half compared to GFP Dynein plus end intensity without BicD2400 (black 
curve). Error bars shown are standard deviations of mean intensity profiles from three experiments for 
each condition. * P value < 0.0001 by Student two tailed t-test. 
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4.2.4 Lis1 regulates dynein transport and its microtubule localisation in 
dose dependent manner 
The work presented so far in this chapter shows that the dynactin complex and EB1 are 
sufficient for plus-end localisation of dynein. However, in non-neuronal cells, this 
pathway required additional regulator—Lis1 (Coquelle et al., 2002; Splinter et al., 
2012). It is possible that Lis1 is required to maintain dynein at plus ends by repressing 
its processive motion.  To test this hypothesis, I studied whether Lis1 could rescue the 
reduced plus end accumulation of dynein induced by BicD2400 (possibly by activating 
processive dynein motion away from plus ends) in the plus end tracking experiments. 
For these experiments, I expressed and purified full-length human Lis1 with a C-
terminal mCherry tag (mCherry Lis1).  I studied the combined effect of Lis1 and BicD2 
on the plus end tracking of dynein in end tracking experiments where GFP dynein, 
dynactin, EB1, BicD2400, and Lis1mCherry were studied on labelled dynamic 
microtubules. In the end tracking experiments, the concentrations of all the other 
proteins were fixed (10 nM GFP dynein, 20 nM human dynactin, 20 nM EB3 and 5 µM 
BicD2400), while Lis1 was studied at two different concentrations: 1 µM and 5 µM. 
 
Lis1 promotes and restores the microtubule plus end localisation of dynein 
At 1 µM mCherry Lis1, GFP dynein was seen at the plus ends even in the presence of 5 
µM BicD2400. (Figure 4.12 B) However, adding 5 µM mCherry Lis1 caused an increased 
accumulation of dynein at the plus ends, hence restoring the BicD2400 induced reduction 
of plus-end tracking (Figure 4.12 C).  I also observed an overall increased microtubule 
binding of GFP dynein in the presence of Lis1 (Figure 4.12 B and C). However, Lis1 
did not seem to visibly repress the motion of DDB, as hypothesized earlier (Yamada et 
al., 2008; McKenney et al., 2010; Huang et al., 2012).  
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Figure 4.12 Lis1 promotes plus end localisation of GFP Dynein  
(A) Kymograph: At 5 µM of untagged BicD2400, 10 nM GFP Dynein (green in kymograph) not seen at 
plus ends of Alexa 568 dynamic microtubules (red in kymograph) in the presence of 20 nM purified pig 
dynactin and 20 nM EB1. (B) When 1 µM of Lis1 is added together with 5 µM BicD2400 to the end 
tracking experiment, there was an increase in the plus end accumulation of GFP dynein (C) When 5 µM 
Lis1 was added together with 5 µM BicD2400 to the GFP Dynein end tracking experimental condition plus 
end localisation of dynein was restored (shown in kymographs on right). Images were acquired at 200 ms 
exposure 488 nm and 561 nm channel, and 500 frames were acquired at a frame rate of 1 fps. The 
temperature was 30oC. 
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4.12 D. 
 
 Figure 4.12.D The average GFP Dynein intensity at plus ends 
 The averaged GFP Dynein intensities profile at plus ends in the presence of 1 µM Lis1 (blue curve) 
showed an increase in plus end localisation of GFP dynein even in the presence of BicD2400 compared to 
diminished GFP Dynein plus end intensity when 5 µM BicD2 alone was added (black). At 5 µM Lis1 
(red curve) there was a further increase in the plus localisation of dynein. Error bars shown are standard 
deviations of mean intensity profiles from three experiments for each condition. * P < 0.0001 (Student 
two tailed t-test). 
 
 
Lis1 initiates DDB motion 
Adding Lis1 to the GFP-dynein plus-end tracking assay together with BicD2 did not 
impede the processive motion; rather, an increase in the frequency of DDB events was 
noticed (Figure 4.13C and D). This was not surprising, considering the established role 
of Lis1 as an initiation factor for dynein motion in fungi and neurons (Egan et al. 2012, 
Lenz et al. 2006, Moughamian et al. 2013). At 1µM Lis1 (Figure 4.13C), there was 
more than twofold increases in the number of motile events compared to the events 
from assays where DDB alone (Figure 4.13 A) or DDB with EB1 were studied (Figure 
4.12 B). This observation suggests that Lis1 indeed acts as an initiator of DDB motion.  
Unexpectedly, at higher Lis1 (Figure 4.12C), there was a drop in the number of motile 
events (from 2 events/µm of MT length to 1.2 events/µm of MT length) (Figure 4.13D). 
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The reason behind this decrease in motile DDB events at high Lis1 concentration is not 
clear, but it does appear that at 5 µM Lis1 might outcompete BicD2400 to repress dynein 
motility and maintain dynein at microtubule plus-ends (as seen in the GFP-dynein plus 
end tracking experiment in Figure 4.12).  From the end tracking experiments with 1 µM 
and 5 µM Lis1, it appears that 1 µM Lis1 is the concentration regime where high 
motility is observed while 5 µM Lis1 is the regime of increased plus end tracking. 
 
 
 
Figure 4.13 Lis1 increases the number of motile DDB events 
(A) Kymograph showing DDB events. (B) DDB events in presence of EB1. (C) DDB events in presence 
of EB1 and 1 µM Lis1. Images were acquired at 200 ms exposure 488 nm (GFP dynein) and 640 nm 
(Alexa 647 microtubule) channels, and 500 frames were acquired at a frame rate of 1 fps. The 
temperature was 30oC. 
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D. 
 
E.                                                                                F. 
 
Figure 4.13 Lis1 increases the number of motile DDB events 
(D) Frequency of motile events per micron of microtubule length, bar represents individual frequency of 
motile dynein in DDB complex alone, in presence of EB1, and 1 µM and 5 µM of Lis1 together with EB1. 
*P value equals 0.1486 (not statistically significant), ** P < 0.0001 (statistically significant) *** P < < 
0.001 (statistically significant). Mean run length (E) and mean velocity (F) of processive DDB in 
presence of EB1 and in presence of 1 µM Lis1 together with EB1. Error bar is the standard deviation. 
Error bar shows standard deviation.  P values (unpaired t-test) equals 0.84 and 0.97 for E and F 
respectively (not statistically significant indicated as n.s.) 
 
Next, I studied if mCherry Lis1 is bound to processive DDB during its run. For this, I 
imaged GFP dynein and mCherry Lis1 sequentially. mCherry Lis1 was not seen on 
motile DDB (Figure 4.14). This agrees with the reported transient nature of Lis1-dynein 
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interaction (Egan et al., 2012; McKenney et al., 2011). Further, Lis1 is known to slow 
down dynein driven motion (Huang et al., 2012; McKenney et al., 2010;Torisawa et al., 
2011; Yamada et al., 2008). However, I did not observe a reduction in the DDB velocity 
or run length when Lis1 was added (Figure 4.13 E and F), further supporting the 
evidence that processively moving DDB was not bound to Lis1. Surprisingly, I did 
observe mCherry Lis1 localise at dynamic microtubule plus ends (Figure. 4.14). Since 
Lis1 can directly bind to both dynein and dynactin (Dix et al., 2013; Tai et al., 2002; 
Wang et al., 2013), it is possible that dynein-dynactin recruit Lis1 to the plus ends. 
Supporting this hypothesis, dynein and dynactin have indeed been shown to recruit Lis1 
at the plus ends of kinetochore microtubules in cultured mammalian cells (Tai et al., 
2002).  To sum up, the data suggest that Lis1 did not bind to moving DDB perhaps due 
to competition with BicD2 (see discussion in section 4.3.4); instead Lis1 localised (and 
possibly interacts) with the dynein-dynactin complex at the plus ends. 
 
 
Figure 4.14 Three colour imaging of GFP dynein and mCherry Lis1 on dynamic 
microtubules in the presence of dynactin BicD2 and EB1.  
Kymograph: Showing 5 µM mCherry Lis1 colocalisation with 10 nM GFP dynein, in presence of 10 nM 
pig dynactin complex and 20 nM EB1 on Atto 647 labelled dynamic microtubules mCherry. Lis1 did not 
colocalise with processive DDB runs. 
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Lis1 enhances the recruitment of GFP dynein to the microtubules 
It is unclear how Lis1 may initiate dynein transport. One possibility is that Lis1 
enhances the overall recruitment of dynein to the microtubules, where DDB could be 
assembled; hence the transport initiation could take place all over the microtubules. To 
test this, I studied the plus end tracking of GFP dynein in the presence of dynactin, EB1 
and 5 µM mCherry Lis1. Here, GFP dynein localised not only to the plus ends, but all 
over the microtubules either statically bound or diffusing along the microtubules 
(Figure 4.15 B). Therefore, consistent with the previous reports (Huang et al. 2012, 
McKenney et al. 2010, Toropova et al. 2014, Yamada et al. 2008), Lis1 appears to be a 
general microtubule recruiter of dynein rather than a specific plus end recruiter and its 
property of enhancing dynein’s microtubule attachment seems to be the mechanism by 
which Lis1 initiates dynein transport. This idea is also consistent with studies in neurons 
where Lis1 initiated transport along the entire microtubule length and not just the plus 
ends (Moughamian et al., 2013). 
 
Figure 4.15 Lis1 recruits GFP Dynein to dynamic microtubules  
(A) Kymograph: 10 nM GFP Dynein (green) seen at plus ends of Alexa 568 dynamic microtubules (red) 
in the presence of 20 nM purified pig dynactin and 20 nM EB1. Image was acquired at 200 ms exposure 
488 nm and 640 nm channel, and 500 frames were acquired at a frame rate of 1fps. The temperature was 
30oC (B) When 5 µM of mCherry Lis1 was added to the same GFP Dynein end tracking experimental 
GFP dynein decorated the dynamic microtubule filaments, including plus ends. 
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Figure 4.15 Lis1 recruits GFP Dynein to dynamic microtubules  
(C) Averaged GFP Dynein intensities distribution at plus ends in the presence of 5 µM Lis1 (red curve) 
shows an overall increase in GFP dynein intensity compared to GFP Dynein plus end intensity without 
Lis1 (black curve). 
 
In conclusion, two important roles of Lis1 were uncovered in this study: first as a 
promoter of plus end accumulation of dynein in the presence of processivity factors; 
and second as an initiator of DDB motion. Both these roles appear to be dose dependent. 
In the presence of the same amount of BicD2400 and Lis1, plus end accumulation of 
dynein was favoured, while the BicD2 induced processive dynein motion appeared 
suppressed. When Lis1 was present in lower concentration than BicD2400 there was an 
increased initiation of DDB motion, perhaps because of increased dynein recruitment to 
the microtubules where DDB complex is possibly assembled. Further, Lis1 seems to 
recruit dynein all over the microtubule, including the plus ends when BicD2 was 
omitted from the plus-end tracking assay. Therefore, it appears that in this study Lis1 
and BicD2 compete to shift dynein’s microtubule localisation and its processive motion.  
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4.3 Discussion 
In this chapter, I presented an in vitro characterization of the plus-end localisation and 
processive motion of the recombinant human dynein complex on dynamic microtubules. 
I studied how the key dynein regulators dynactin and Lis1, adaptor protein BicD2, and 
end binding protein EB1, guide dynein’s recruitment to the microtubule and regulate its 
processive motion.  First, dynein in the presence of dynactin and BicD2400 (DDB) 
showed processive motion on dynamic microtubules. Second, dynactin and EB1 was 
necessary for plus end tracking of GFP dynein. The DDB complex did not appear to 
track the plus ends of the microtubules, and high amounts of BicD2 reduced the end 
tracking of dynein in the in vitro end-tracking assay. Addition of Lis1 to the plus end 
tracking assay together with BicD2 showed a concentration dependent regulation of 
dynein, where an increased Lis1 concentration represented a plus end tracking regime 
and five times lower Lis1 represented high motility regime.  
 
4.3.1 Regulation of microtubule localisation of human dynein 
GFP human dynein localised to the microtubule plus ends in the presence of the purified 
dynactin complex and EB1. How does the supposedly folded and auto-inhibited 
dynactin subunit p150 (Chowdhury et al., 2015; Urnavicius, 2015) mediate its 
interactions with dynein and EB1? It is possible that the p150 CAP-Gly is exposed in 
the folded dynactin conformation, allowing its interaction with EB1, and transient but 
frequent dynein-dynactin interaction leads to their plus-end localisation. Since the CAP-
Gly domain was not visualised in the recent dynactin structures (Chowdhury et al., 
2015; Urnavicius, 2015), its orientation in the dynactin complex is unclear. However, 
based on the GFP dynein plus-end tracking experiment presented in this chapter, it may 
be speculated that the CAP-Gly domain and at least one of the dynein binding sites 
(CC1 or Arp1) of dynactin are not permanently masked.  
I observed GFP human dynein tracking both growing and shrinking microtubule plus 
ends. In dividing cells, the interaction of shrinking microtubule ends with dynein at the 
kinetochore has been implicated in mediating chromosome separation during anaphase 
(Savoian et al., 2000; Sharp et al., 2000). Further, the pulling force exerted by dynein 
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with end-on attachment to the shrinking cortical microtubules is thought to be necessary 
for spindle positioning (Carminati and Stearns, 1997; Dujardin and Vallee, 2002; Grill 
et al., 2001; Koonce et al., 1999; Vallee et al., 2006; Yamamoto et al., 2001). The 
molecular mechanism behind the tracking of the shrinking plus ends remains poorly 
understood. It is possible that once recruited to the growing plus ends by dynactin and 
EB1, dynein independently remains bound to the depolymerising plus ends. Whether 
the dynactin complex colocalises with dynein at the shrinking plus ends is unclear. 
However, in cells dynactin’s p150 did not track the shrinking plus ends (Dixit et al., 
2008)   
The dynactin-dependent end tracking of dynein did not require its motor activity, as 
dynein could track plus ends in the absence of ATP. For plus-end tracking, vertebrate 
dynein in fact hitchhikes its +TIP interacting regulators, dynactin complex in this 
case(Duellberg et al., 2014; Moughamian et al., 2013). Further, I showed that by 
binding to microtubule plus ends, dynein-dynactin induced an increase in microtubule 
growth velocity in agreement with the role of dynactin (p150) as a microtubule 
polymerase (Lazarus et al., 2013). Further characterization of other aspects of 
microtubule dynamics in the presence of dynein and dynactin will strengthen our 
knowledge of their role at plus ends.  
 
4.3.2 Plus end tracking versus minus-end transport: Role of BicD2  
The role of BicD2400 as an activator of processive dynein-dynactin motion has been 
studied extensively (Chowdhury et al., 2015; McKenney et al., 2014; Schlager et al., 
2014; Urnavicius, 2015). In this thesis, I studied another role of BicD2400 as an 
antagonist of dynein’s plus-end tracking behaviour. The results suggested that the DDB 
tripartite complex does not localise at microtubule plus ends, and at 5 µM BicD2400, 
there is a clear abrogation of dynein’s plus-end tracking behaviour. What is the 
molecular mechanism of this BicD2400 induced removal of dynein from the microtubule 
plus ends? In principle, there could be a BicD2400 induced allosteric modulation in the 
dynein-dynactin complex, which might prevent their interaction with EB1. 
Alternatively, the activation of dynein-dynactin motion in the presence of BicD2 could 
deplete the accumulated dynein pool at plus ends.  This BicD2 induced depletion of 
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dynein from plus ends is reminiscent of the Num1 (yeast adaptor protein) fragment 
mediated removal of dynein from the microtubule plus ends seen in budding yeast 
(Lammers and Markus, 2015). Thus, similar to the biasing property of Num1 in budding 
yeast, BicD2 also seems to bias human dynein’s behaviour from a non-processive plus-
end tracking motor to a processive minus-end directed motor. Whether this biasing 
property can be generalised to other cargo adaptors of metazoan dynein remains to be 
tested.  
 
4.3.3 Lis1 promotes and restores plus end tracking of dynein 
Lis1 has been found to regulate several dynein properties across species (Cianfrocco et 
al., 2015; Kardon and Vale, 2009). Here, I investigated the role of Lis1 in controlling 
human dynein’s plus-end tracking behaviour and its minus-end directed motion. Lis1 
acts as a general microtubule recruiter of dynein-dynactin; however, in combination 
with BicD2, differential dynein-dynactin regulation was observed. 5 µM Lis1 could 
restore plus-end tracking of human dynein even in the presence of 5 µM BicD2. This 
observation supports the necessity of Lis1 in the plus end localisation of dynein in non-
neuronal mammalian cells. In cells, several cargo adaptors drive dynein motion away 
from the plus ends, and Lis1 could conceivably inhibit dynein motion to sustain its plus-
end localisation. 
 
 
4.3.4 Lis1: An initiator of dynein motion 
At a Lis1 concentration showing high motility in the dynein end tracking assay, a high 
number of motile DDB events were observed. This agrees with the previously studied 
role of Lis1 as an initiator of dynein transport in filamentous fungi (Lenz et al., 2006; 
Egan et al., 2012) and neurons (Moughamian et al., 2013). How does Lis1 promote the 
initiation of dynein transport? By increasing the dynein-dynactin recruitment to the 
microtubules, Lis1 probably favours the assembly of DDB complex on the microtubules. 
However, the binding of Lis1 to DDB, appeared transient, suggesting that Lis1 
dissociates from the activated processively moving DDB complex. Therefore, BicD2 
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and Lis1 seem to compete for binding to the dynein-dynactin complex. However, Lis1 
and BicD2 do not appear to share any binding site on dynein-dynactin; thus, the release 
of Lis1 upon BicD2 binding is likely allosterically governed.  
At a Lis1 concentration showing high plus end tracking, I saw a decrease in the number 
of DDB runs, compared to when fivefold lower Lis1 was present. This surprising effect 
of reduced initiation at higher Lis1 concentration could be because Lis1 outcompetes 
BicD2 to favour the assembly of a non-processive dynein-dynactin-Lis1 complex thus 
preventing the formation of a processive DDB complex. This study provided direct 
evidence of Lis1 as an initiation factor and regulator of microtubule end localisation of 
dynein. Lis1 regulations seems to be multi-layered and dose-dependent. However, the 
picture is incomplete without the additional binding partner of Lis1, NudE/L, which 
further regulates the plus-end localisation and the transport properties of dynein (Huang 
et al., 2012; McKenney et al., 2010; Wang and Zheng, 2011). Furthermore, Lis1’s 
interaction with CLIP170 (Coquelle et al., 2002; Tai et al., 2002), may provide yet 
another layer to dynein regulation.  
 
4.3.5 Sequential regulation of multiple steps of dynein transport 
The overall effect of dynein regulation studied here highlights an emergent role of Lis1 
and BicD2 in controlling the plus-end tracking behaviour and the processive minus end 
directed motion of the dynein-dynactin complex. The direct implication of these 
multiple modes of dynein regulation could be in sequentially guiding each step of 
dynein driven cargo transport. From the data shown in this chapter, it is clear that 
dynein is recruited to microtubule plus ends by dynactin and EB1. Lis1 acts as recruiter 
of dynein to the microtubules, which together with BicD2, initiates dynein motion and 
at high concentration outcompetes BicD2 to increase the microtubule localisation of 
dynein to microtubule ends. 
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Chapter 5. Materials and Methods 
5.1 Molecular Biology  
For cloning DNA inserts were amplified from cDNA clones or preexisting expression 
plasmids using Kappa HiFi polymerase (KapaBiosystems; KK 2101) according to the 
manufactures recommendation. All the cloning was done using In-fusion (Clontech), 
which offers ligation free method. For this method, primers had to be generated so that 
the PCR amplicon contained 15 basepairs (bp) homologous to each end of the vector. 
The 5’ end of the primer was vector specific and 3’ end of the primer was gene-specific. 
All Primers were synthesized and purchased from Sigma Aldrich (desalt grade) and 
annealing temperatures were calculated using APE freeware   
(http://biologylabs.utah.edu/jorgensen/wayned/ape/).  
     Table 5.1 List of Primers 
Primers for  Sequence (5’ to 3’) 
Subcloning mGFP in 
the pdyn1 construct 
Forward: CTCTATTTCCAGGGTATGAGCGTGAGCAAGG 
Reverse: CTCTATTTCCAGGGTATGAGCGTGAGCAAGG 
pdyn1 
Vector amplification 
Forward: GGTTCTTCCGAACCTGGCG 
Reverse: ACCCTGGAAATAGAGATTCTCTGTAGTTGG 
 
His6SNAP 
Forward: TATTTTCAGGGCGCCCGACAAAGATTGCGAA 
Reverse: GCCGACATGCCGCCACCGCCACC 
 
His6BicD2400 
Forward: TATTTTCAGGGCGCCGGAGGTGGCGGTGGCG 
Reverse: TTCGGATCCGGTACCTTACAGGCGCCGCAGGG 
 
His6SNAPBicD2400 
Forward: TGGCGGCATGTCGGCGCCGTCG 
Reverse: TTCGGATCCGGTACCTTACAGGCGCCGCAGGG 
 
For gel extraction, PCR proucts were resolved on agarose gel, extracted, and purified 
using Gel Extraction Kit (Qiagen 28704). Vectors were linearised for 1 hour using 
standard restriction enzymes (all for New England Biolab, NEB, see table 2) and 
vectors were subsequently treated with Antarctic Phosphatase (NEB, M0289S) for 
another hour at 37˚C. After heat inactivation at 75 ˚C for 20 minutes, the vector and 
PCR amplicon were purified using the QIAquick Gel Extraction Kit. DNA 
concentrations were measured by spectrophotometer (Nanodrop). Inserts and linearized 
vectors were mixed in a 3:1 molar ratio and incubated with In-fusion enzyme mix for 15 
minutes at 50oC.  
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Then 50 μl of XL1 Blue E. coli cells (Stratagene) were transformed with 5 μl of 
infusion ligated mix using standard heat shock procedures (Froger and Hall, 2007) and 
Ampicilin (100 μg/μl,) or Kanamycin (50 μg/μl,) as a selection marker for agar plates. 
Plasmid DNA was isolated using QIAprep Spin Miniprep Kit (27104) from 6 ml liquid 
overnight cultures (at 37˚C, 160 rpm).  Positive clones were selected by checking for 
inserts by restriction digestion followed by agarose gel electrophoresis and ethidium 
bromide staining. Sequences were confirmed by sequencing at GATC-Biotech 
(http://www.gatc-biotech.com).  
 
Subcloning His6mGFP in the pdyn3 construct  
The dynein construct coexpressing all the six dynein subunit in one Multibac insect cell 
expression construct, called pDyn3 (Schlager et al., 2014) was gifted by Dr. Andrew 
Carter’s lab (MRC LMB, Cambridge). The original pdyn3 construct was formed by Cre 
recombination of two plasmids (Schlager et al., 2014): pdyn1, where DHC (accession 
number NM_001376.4), with N-terminal His tag and SNAP tag was cloned into 
pACEBac1 (Vijayachandran et al., 2013); and pdyn2 with remaining 5 subunit of 
dynein DIC2 (AF134477), DLIC2 (NM_006141.2), Tctex1 (NM_006519.2), LC8 
(NM_003746.2) and Robl (NM_014183.3) cloned into pIDC plasmid (Vijayachandran 
et al, 2013).   
To generate the mGFP dynein complex from the original plasmid I replaced the N-
terminal SNAP tag of pdyn1with the mGFP tag. The mGFP tag was PCR amplified 
from preexisting plasmid (mGFP-cc-yeastDyn331). The vector pdyn1 except the SNAP 
tag was also amplified by PCR. The amplified pdyn1 vector and mGFP tag was purified 
by gel extraction and ligated by Infusion enzyme (Clontech), as described above in this 
section. The mGFP pdyn1 was then fused to pdyn2 by using an in vitro Cre reaction 
(New England Biolabs) following the manufacturer’s protocol to generate mGFP 
pDyn3. Briefly, the 0.3 µg pdyn1 and 0.2 µg pdyn2, 5 µl of Cre recombinase rection 
buffer, 1 µl of Cre recombinase enzyme, were mixed and ultrapure water was added to 
make the final reaction volume to 50 µl. This reaction was incubated at 37oC for 30 
minutes and then at 70oC for 10 minutes, followed by transformation in XL1 Blue E. 
coli competent cells (Stratagene). The positive colonies were identified by PCR against 
all six dynein subunits and were further verified by sequencing. 
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5.2 Gel electrophoresis  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE, (Laemmli, 
1970)) for protein visualisation was done using NuPAGE 4-12% gradient gels 
(Invitrogen). Protein samples were denatured by adding Laemmli buffer and boiled at 
70oC for 10 minutes. A molecular weight marker, Precision plus Protein Standards 
(BioRad, 161- 0377) were used to identify the protein based on molecular weight. Gels 
were stained using coomassie brilliant blue (Meyer and Lamberts, 1965), and destained 
using buffer containing50% methanol, 10% glacial acetic acid.  
The protein gels that were sent for mass-spectrometry were stained by commercial stain 
InstantBlue (SigmaAldrich) for 15 minutes and rinsed by distilled water for 5 minutes. 
The bands to be analysed were excised from the gel and sent to the proteomic 
laboratory for further processing. Gels from final step of dynactin purification from 
HeLa S3 cells were stained overnight with SYPRO ruby (Invitrogen), washed with 
ultrapure water and imaged using Image Quant LAS 400 detector (GE Healthcare). 
For identification and processing of DNA agarose gel electrophoresis was performed 
using standard methods. Tris-Acetate-EDTA was used as running buffer and resolved 
gels were stained with ethidium bromide to visualize DNA. The stained DNA gel was 
visualized using Image Quant LAS 400 detector (GE Healthcare).  
 
5.3 Western Blotting  
           Table 5.2 List of antibodies for Western blotting 
Primary 
Antibody 
Raised in Epitope Company Dilution 
Anti His Mouse 6X His tag Qiagen 1:2000 
Anti DIC Rabbit Dynein Intermediate Chain Invitrogen 1:1000 
Anti DHC Rabbit Dynein Heavy Chain Eurogentec 1:1000 
Anti p150 Mouse Dynactin p150subunit BD bioscience 1:2000 
Secondary Antibody    
Goat anti Rabbit HRP  Santacruz 1:10,000 
Goat anti Mouse HRP  Santacruz 1:5000 
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Western blotting was performed to identify expressed and purified dynein and dynactin, 
and to monitor His tag cleavage from recombinant proteins by TEV protease using the 
primary and secondary antibodies listed in the Table 5.2. Protein samples were first 
resolved by SDS-PAGE, and then transferred onto the nitrocellulose membranes 
(Whatman Protran) using a tank-blotting chamber (Bio Rad) for 2 hours at a constant 
current of 300 mA in precooled transfer buffer in a cold room (4 ˚C). The transfer buffer 
used was: 0.025 M Tris, 0.192 M Glycine and 20 % Methanol (Towbin et al., 1992). 
The membranes with the protein of interest were first blocked by 5% nonfat milk 
(dissolved in PBST buffer- PBS and 1% Tween-20) for 1 hour at room temperature, 
followed by three rounds of washes with PBST buffer. Blocked membranes were then 
incubated with primary antibody (diluted in blocking solution) against the protein of 
interest for 2 hours at room temperature. Membranes were washed thrice with PBST for 
5 minutes each and then incubated with horseradish peroxidase conjugated secondary 
antibody (diluted in blocking solution) for 1 hour, then washed with PBST (three times, 
5 minutes). Finally, chemiluminescence substrate (from Amersham ECL Advance – 
Western Blotting detection Kit) was added to the blot and the signal was visualised 
using an Image Quant LAS 400 detector (GE Healthcare). 
 
5.4 Protein expression 
5.4.1 Protein expression in E. coli 
Proteins were expressed in Escherichia coli BL21-RIL competent cells (Stratagene, Cat 
no: 230240). For expression in E. coli, 100 ng of plasmid DNA was added to 50 μl of 
cells and incubated on ice, followed by heat shocked for 45 seconds at 42˚C and 
transferred back on ice for 5 minute supplemented with 1 ml standard LB medium 
(media kitchen LRI) and incubated for 1 hour at 37˚C.  The LB medium with grown 
transformed cell was then spread onto agar plates (media kitchen, with 30 μg/μl 
Chloramphenicol and Kanamycin (30 μg/μl) or Amplicilin (100 μg/μl). Agar plates 
were incubated over night at 37 ˚C. On the following day, a single colony was picked 
for an overnight culture (1 l LB medium, supplemented with antibiotics and 2% 
Glucose at 160 RPM and 37˚C using a 5 l Erlenmeyer flask and a shaker. On the next 
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day, overnight cultures were diluted 1:10 in LB medium containing antibiotics and (but 
without glucose) and were transferred to 37˚C while shaking at 160 RPM was 
maintained. The cell proliferation was monitored using the OD600 on a conventional 
spectrophotometer (Ultrospec 3100 pro, Amersham). Once an OD600 of 0.8 was reached, 
the cultures were transferred to 18˚C and expression was induced with 1 mM Isopropyl 
β-D-1-thiogalactopyranoside (Roche, 11411446001) overnight. The next day, cells 
were harvested by centrifuging (20 min, 4000g, JLA 81000 rotor (Beckman) 4 ˚C) and 
the pellets were recovered. The Pellets were re-suspended in ice-cold PBS (10 mM 
Na2HPO4, 18 mM KH2PO4, 27 mM KCl, 137 mM NaCl, pH 7.4), transferred into 50 
ml Falcon tubes (Corning) and centrifuged (15 min, 4000g, centrifuge (Multifuge X1R, 
Thermo). The washed cell pellet was flash frozen and stored at -80oC. 
 
5.4.2 Insect cell culture and expression 
Sf21 (Spodoptera frugiperda 21) insect cells (originally provided by Imre Berger, 
EMBL Grenoble) and Sf-900 II SFM serum-free medium (Invitrogen) was used cell 
culture. Cells were counted every 24 h and maintained at 0.5 x 106 cells/ml in 
Erlenmeyer flasks (Corning, Sigma Aldrich) of five times the cell culture volume. 
DH10MultiBac10 cells (Bieniossek et al., 2012). (Life technologies) were used for 
generation of the recombinant bacmids. DH10 MultiBac cells were transformed with 
100 ng pFastBac vector (Fitzgerald et al., 2006) containing the gene of interest using 
standard electroporation (Dower et al., 1988) and were grown in SOC (Life 
technologies) medium for 6 hours and plated onto agar plates with Gentamycin (7 
μg/ml), Teracyclin (10 μg/ml), Kanamycin (50 μg/ml), Bluo-Gal/X-Gal (0.1 mg/ml) 
and Isopropyl β-D-1- thiogalactopyranoside (40 μg/ml). Colonies were selected based 
blue white screen, (Ullmann et al., 1967) after 2 days at 37 ˚C. To confirm selection of 
positive clones and to check if the colonies maintained colour, the colonies were 
restreaked and incubated for another 2 days. Bacmids were isolated from 100 ml LB 
overnight cultures (160 RPM, 37 ˚C) using NucleoBond® Xtra Midi prep kits 
(Macherey-Nagel, 740410.10). 
Freshly prepared recombinant bacmids in combination with FuGENE transfection 
reagent (Roche) were used to transfect Sf21 cells in 6-well plates used for tissue culture. 
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Viruses were collected 48 hours after the transfection and used for virus amplification 
and to obtain high-titer viruses. Generally, 2 ml of initial viruses were used for infection 
of 25 ml of Sf21 cell culture (at 0.6x106 cells/ml) and the cells were split every 24 hours 
to 0.6x106 until Sf21 cells were arrested. Viruses were collected 48 hours after 
proliferation arrest. These second generations of high-titer viruses were used for large-
scale (~600 ml) expression of the recombinant proteins in Sf21 cells. The viruses were 
used in a dilution that allowed one round of doubling of the infected Sf21 cells before 
cell proliferation was arrested (low multiplicity of infection) (Fitzgerald et al., 2006). 
The dynein complex subunits, His6-GFP-DHC and DIC1 were expressed for 60 h after 
proliferation arrest. The pdyn3 construct, the three constructs of His6-GFP-cc-
Dyn380kD with different linker lengths, His6-GFP-yeast-Dyn331kD, and Lis1-
mCherry-His6 were expressed for 72 h after the arrest. After the expression, the cells 
were harvested by centrifugation at 6,000 rpm at 4oC (JLA 8.1 rotor). The pellets were 
washed with ice-cold PBS, flash frozen and stored at -80oC. 
 
 
 
5.5 Protein Purification  
5.5.1 Recombinant human dynein complex 
The human dynein complex used in this thesis were expressed and purified from insect 
cells by two methods: 
 
1. Step-wise assembly of dynein subunits expressed sepeartely 
2. Coexpression and purification of all the six dynein subunits from a single plasmid 
For the step-wise assembly of the dynein subunits the method described in (Trokter et 
al., 2012) was followed. The full-length dynein heavy chain (DHC), with N-terminal 
His tag followed by an mGFP tag, was expressed in Sf21 cells(Trokter et al., 2012). The 
dynein intermediate chain 1 (DIC1) was expressed in separate Sf21 culture (Trokter et 
al., 2012). The other dynein subunits, dynein light intermediate chain2 (DLIC2), light 
chains (LCs: Roadblock, Tctex1, LC8) were expressed and purified from E. coli 
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(Trokter et al., 2012). The full-length DHC protein is insoluble and requires DIC and 
DLIC2 for solubility (Trokter et al., 2012). Therefore, for solubility of dynein the DHC 
and DIC lysates and purified DLIC2 were mixed, and this dynein subcomplex is 
purified by immobilized metal affinity chromatography (IMAC) (Trokter et al., 2012). 
The LCs were then added to the affinity purified dynein subcomplex. Further 
purification by gelfiltration allowed separation of the aggregated dynein complex and 
nonspecific proteins from the fully assembled dynein complex (Trokter et al., 2012).  
 
Detailed purification protocol  
At the beginning of the purification, the affinity column (HiTrap chelating HP 5ml) was 
washed with 3 column volumes (CVs) ultrapure water, 1 CV CoCl2, 3 CVs water, 10 
CVs lysis buffer (50 mM HEPES, 250 mM K-acetate, 2 mM MgSO4, 0.25 mM EDTA, 
10% glycerol (vol/vol), 0.2 mM Mg-ATP, 1 mM β-mercaptoethanol, 20 mM imidazole, 
pH 7.4, protease inhibitors (Complete EDTA-free, Roche)). Pellet of His6-mGFP-
CDHC from ~1 L Sf21 heavy chain and pellet of DIC1 from ~250 ml were thawed and 
resuspend in ~30 ml of ice-cold lysis buffer and mixed together. Resuspended pellet 
mixture of DIC and CDHC was then lysed using a dounce homogenizer (20 tight 
strokes). 2 mg of purified LIC2 was added to the lysates. The lysate was then clarified 
by centrifugation at 50,000 rpm for 30 minutes at 4°C (Ti70 rotor), and the supernatant 
was recovered and kept at 4°C. The clarified lysate was applied to a 5 ml HiTrap HP 
column loaded with Co2+ ions equilibrated in lysis buffer at 1 ml/min flow rate.  
After loading the column was washed with the lysis buffer equivalent to 15 CVs. The 
mixture of His6-mGFP-DHC, DIC1, and LIC2 was eluted with elution buffer (50 mM 
HEPES pH 7.4, 250 mM K-acetate, 2 mM MgSO4, 0.25 mM EDTA, 10% glycerol 
(vol/vol), 0.2 mM Mg-ATP, 1 mM β-mercaptoethanol, 350 mM imidazole, protease 
inhibitors (Complete EDTA-free, Roche)), and collect 0.5 ml fractions. To the affinity-
purified dynein (containing three subunits), 150 µg of each light chains (LC8, RB1 and 
Tctex1 purified from E. coli) was added, followed by buffer exchange (using PD10 
column) into gel filtration buffer (30 mM HEPES pH 7.2, 150 mM K-acetate, 2 mM 
MgSO4, 0.5 mM EGTA, 10% glycerol (vol/vol), 0.05 mM Mg-ATP, 10 mM β-
mercaptoethanol). His6 tag of DHC was cleaved with TEV protease; by adding 1 mg 
TEV per 30 mg protein and incubated overnight at 4°C. 
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The affinity purified dynein complex was further purified by gel filtration using protein 
using Superose 6 XK 16/70 prep grade column equilibrated in gel filtration buffer. The 
dynein containing fractions were pooled (fractions close to the column void volume was 
not collected) and concentrate using Vivaspin column with 50 kDa cut-off (up to 0.2 
mg/ml). The concentrated protein was centrifuged at 100,000 g for 10 minutes at 4°C 
(TLA 120 rotor). The purified protein (Figure 5.2) was supplemented with 10% glycerol 
(vol/vol), flash frozen in 5 µl aliquots and store in liquid nitrogen. The final 
concentration was 0.18 mg/ml.  
The human dynein complex was also purified from mGFP pdyn3 construct that 
expressed all the six dynein subunit from one plasmid, as described in (Schlager et al., 
2014). The cell pellet (~800 ml) transfected with GFP pdyn3 expressing all the dynein 
subunits was resuspended in the lysis buffer (50 mM HEPES pH 7.4, 250 mM K-acetate, 
2 mM MgSO4, 0.25 mM EDTA, 10% glycerol (vol/vol), 0.2 mM Mg-ATP, 1 mM β-
mercaptoethanol, 20 mM imidazole, protease inhibitors (Complete EDTA-free, Roche)) 
and lysed by dounce homogenization, clarified by centrifugation following the same 
procedure as described in the above protocol. The complex was purified by IMAC 
(Figure 5.1A) via the His tag on the DHC subunit and further purified by gel filtration 
(gel filtration buffer was: 30 mM HEPES pH 7.4, 150 mM K-acetate, 2 mM MgSO4, 
0.5 mM EGTA, 10% glycerol (vol/vol), 0.05 mM Mg-ATP, 10 mM β-mercaptoethanol) 
using Superose 6 XK 16/70 prep grade (Figure 5.1 B and C). The dynein complex was 
pooled supplemented with 10% glycerol and flash frozen in 5 µl aliquot size and stored 
in liquid nitrogen. The final concentration was 0.30 mg/ml. 
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Figure 5.1 Purification of the human dynein complex from mGFP pdyn3 
(A) SDS-PAGE of IMAC purification of recombinant dynein complex; Lysate: the clarified lysate that 
was loaded on to the column for IMAC purification. IMAC eluted fractions: the fractions eluted by 
imidazole and pooled. TEV cleaved: dynein complex after His tag purification. Concentrated: TEV 
cleaved dynein complex concentrated before gel filtration (B) Gel filtration elution profile. Red and black 
curves are GFP and 280 nm absorbance respectively. (C) SDS-PAGE of gel filtration of recombinant 
dynein showing: IMAC purified: Dynein after the first round of purification. Desalted: Dynein eluted 
from IMAC column was exchanged into gel filtration buffer using PD10. Concentrated: the desalted 
dynein complex was concentrated before loading to Superose 6 XK 16/70 prep grade column. Pooled 
fractions: Fractions from gel filtration containing dynein that was pooled and stored (also shown in the 
gel filtration profile). D. SDS-PAGE of dynein complex showing dynein subunits.  
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5.5.2 Artificially dimerised human dynein fragment 
The His6-GFP-cc-Dyn380kD of different linker lengths were expressed in Sf21 cells.  
Typically cell pellet from ~600 ml Sf21 cell culture was used for purification of each 
construct. The pellet was thawed and resuspend in ~20 ml of ice-cold lysis buffer (50 
mM HEPES pH 7.4, 250 mM K-acetate, 2 mM MgSO4, 0.25 mM EDTA, 10% glycerol 
(vol/vol), 0.2 mM Mg-ATP, 1 mM β-mercaptoethanol, 20 mM imidazole, protease 
inhibitors (Complete EDTA-free, Roche)). The resuspended pellet was lysed using a 
glass homogenizer (20 tight strokes). The lysate was clarified by centrifugation at 
50,000 rpm for 30 minutes at 4°C (Ti70 rotor). The supernatant was recovered and 
applied to the HiTrap HP column loaded with Co2+ ions equilibrated in lysis buffer at 1 
ml/min flow rate. After loading the column with lysis buffer (10 CV) and eluted with 
elution buffer (50 mM HEPES pH 7.4, 250 mM K-acetate, 2 mM MgSO4, 0.25 mM 
EDTA, 10% glycerol (vol/vol), 0.2 mM Mg-ATP, 1 mM β-mercaptoethanol, 350 mM 
imidazole, protease inhibitors (Complete EDTA-free, Roche)) and collected in 0.5 ml 
fractions. The pooled protein containing fractions were desalted to the buffer into gel 
filtration (30 mM HEPES pH 7.4, 150 mM K-acetate, 2 mM MgSO4, 0.25 mM EDTA, 
10% glycerol (vol/vol), 0.2 mM Mg-ATP, 1 mM β-mercaptoethanol, 20 mM imidazole) 
buffer supplemented with protease inhibitors using a PD10 desalting column. 
His-tag was cleaved using TEV protease (by adding 1 mg TEV per 30 mg protein) and 
cleave overnight at 4°C. The proteins were gel filter the protein using Superose 6 
10/300 GL column equilibrated in gel filtration buffer. The pool dynein containing 
fractions and concentrate using Vivaspin with 50 kDa cut-off, centrifuged at 100,000 g 
for 10 minutes at 4°C (TLA 120). The pooled protein was supplement with 10% 
glycerol (vol/vol), flash freeze in small aliquots and store in liquid nitrogen. The final 
yields of purified His6-GFP-cc-Dyn380kD of the three different linker lengths were 
typically ~2 mg from 500 ml Sf21 cell culture, with a final concentration up to ~1 
mg/ml (Figure 5.2).  
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5.5.3 Artificially dimerised yeast dynein fragment 
His6-GFP-yeastDyn331 was expressed and purified from Sf21 cells. Because of low 
expression of yeast dynein construct, cell pellet from ~1.2 l of culture was used for one 
round of purification. The buffers, purification steps and storage condition were the 
same as described for purification of human dynein fragments. The final concentration 
was 0.3 mg/ml.  
 
5.5.4 Human LIS1  
His6-mCherry-Lis1 was expressed and purified from Sf21 cells using the construct 
cloned by Martina Trokter.  The cell pellet from ~600ml cell culture was resuspended in 
lysis buffer (50 mM HEPES pH 7.4, 100 mM KCl, 1 mM ßME, 0.05 mM ATP, 10% 
(v/v) glycerol, protease inhibitor), lysed using dounce homogenizer and clarified by 
centrifugation. The clarified lysate (40ml in volume) was incubated with 1g of Proteino 
Ni-TED beads (Macherey-Nagel) in a batch format, transferred to a column and washed 
with ~ 100 ml lysis buffer. After washing, the Lis1 bound to the resin via His tag was 
eluted by incubating with TEV protease (5 mg/ml TEV mixed in lysis buffer) for 1 hour 
at room temperature (resuspending the beads every 5 minutes). The cleaved protein was 
separated from the beads by centrifugation (at 1000 g for 2 minutes at 4oC) and the 
supernatant was recovered. The cleaved Lis1-mCherry was concentrated to 0.5ml 
volume and loaded onto Superdex 200 10/300 GL column (GE healthcare) for gel 
filtration (gel filtration buffer was same as lysis buffer). Lis1 containing fractions were 
identified by SDS-PAGE Coomassie staining and pooled. mCherry Lis1 (Figure 5.2) 
was supplemented with 20% glycerol (vol/vol), flash frozen in 5 µl aliquots and stored 
in liquid nitrogen. The final concentration estimated by Bradford was 2mg/ml. 
 
5.5.5 Human BicD2400 
His6-BicD2400 and His6-SNAP-BicD2400 were expressed in BL21 RIL E. coli strain.  
Typically pellets from 4 l cell culture were used for purification of both the BicD2400 
constructs. The pellets were resuspended in lysis buffer (50 mM HEPES pH 7.4, 100 
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mM KCl, 10 mM Imidazole, 1 mM ßME, 0.1 mM ATP, protease inhibitor). The 
resuspended pellet was lysed using a microfluidizer. The lysate was clarified by 
centrifugation (at 38000 rpm for 45 minutes, at 4oC using Ti70 rotor). The clarified 
lysate was loaded onto a prepacked 5 ml HisTrap column (GE Healthcare), which was 
equilibrated with the lysis buffer. Afer loading the column was washed with 20 CVs of 
lysis buffer. The protein was eluted using imidazole contacting elution buffer (50 mM 
HEPES pH 7.4, 100 mM KCl, 300mM Imidazole, 1 mM ßME, 0.1 mM ATP, protease 
inhibitor). The BicD2 containing fractions were pooled and dialysed into gel filtration 
buffer (50 mM HEPES pH 7.4, 100 mM KCl, 1 mM EGTA, 1 mM ßME, 0.1 mM ATP). 
To build BicD2 column used for dynactin purification, the dialysed BicD2400 was stored 
in 1 ml aliquots at -80oC until further use. The final concentration was 10mg/ml. 
Untagged BicD2400 used for reconstitution experiments was further purified by gel 
filtration using Superdex 200 10/300 GL column (GE healthcare). The fractions of 
BicD2400, were pooled, concentrated to 2 mg/ml and flash frozen in 5 µl aliquots and 
stored in liquid nitrogen (Figure 5.2). 
For labelling SNAP-BicD2400, the IMAC purified SNAP-BicD2400 was mixed with same 
molar concentration of Alexa 647SNAP dye, and incubated overnight at 4oC. The 
mixture was the passed through HiPrep 26/60 Desalting columns to remove excess 
Alexa 647 SNAP dye. The fraction containing SNAP-BicD2400 was pooled and further 
purified by Superdex 200 column (GE healthcare). The fractions of Alexa 647 labelled 
SNAP-BicD2400, were pooled, concentrated 0.8 mg/ml and flash frozen in 5 µl aliquots 
and stored in liquid nitrogen. The labelling ratio with Alexa 647-SNAP dye was 1.1. 
 
5.5.6 Human EB3   
I expressed SNAP EB3 from E. coli (BL21 RIL strain) using a construct cloned by 
Julian Gannon (from Surrey Lab). The first round of purification by IMAC was done by 
Johanna Roostalu (from Surrey Lab) following the same procedure described for 
BicD2400 purification. The SNAP EB3 was labelled with Alexa 647-SNAP dye (method 
as described for labelling BicD2400). I carried out the subsequent round of purification, 
using HiPrep 26/60 desalting columns and gel filtration using Superdex 200 10/300 
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column (GE healthcare). The fractions of Alexa 647-SNAP-EB3 were pooled and 
stored at 0.6 mg/ml by flash freezing and storage in liquid nitrogen.  
 
Figure 5.2 SDS PAGE gels of purification of the recombinant proteins  
SDS-PAGE coomassie stained gels of purified recombinant proteins. GFP-cc-Dyn gels of three different 
linker lengths studied in Chapter 2. The lengths DHC sequence in the dynein constructs were: 1303-4646; 
1320-4646; and 1276-4646 amino acids. cc is the kinesin-1 coiled-coil neck linker sequence used for 
dimerisation of truncated DHC fragments. The gels show the final purified protein after gel filtration 
except the SNAP-BicD2400 where both IMAC purified (used for building BicD2 column for dynactin 
purification) and SNAP-BicD2400 after gel filtration (used for reconstitution experiments) is shown in the 
gel.  
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  Table 5.3 Total yield and final concentrations of recombinant proteins 
 
Protein 
Culture volume 
(ml) 
Total yield 
(mg) 
Concentration 
(mg/ml) 
Dynein complex 600 0.5 0.3 
Human dynein artificial dimers 600 2 1 
Yeast dynein artificial dimer 1200 0.2 0.3 
SNAP-BicD2400 3000 20 10 
Alexa 647-SNAP-BicD2400 3000 20 2 
mCherry Lis1 600 2 2 
Alexa 647-SNAP-EB3 3000 1.2 0.6 
 
 
5.6 Extended method of dynactin purification 
In this section I present the detailed protocol for purification of the dynactin complex 
described in Chapter 3. 
i) Preparation of BicD2 Column:  
His6-SNAP-BicD2400 fusions to HiTrap NHS-activated HP column 5 ml. 
Before coupling: Column washed with 3 CV of ice-cold 1 mM HCl 1.5 CV/min 
Coupling BicD2: Continuously recirculating the BicD (1.5 CV/min, 4 CV of a 4 mg/ml 
preparation) for 30 min at room temperature. i.e. about 4ml of purified protein. 
Blocking unreacted group: Unreacted NHS groups were blocked by washing with 6 CV 
of 0.5 M ethanolamine and 0.5 M NaCl at pH 8.3 and then incubated for 30 min at room 
temperature.  
Washing the blocked column: The column was washed with 6x PBS, followed by 1x 
PBS with 50% glycerol (storage buffer) and stored at −20°C.  
Storage and re-equilibrating: Column could be used repetitively if washed between runs 
with: 10 CV of 10× PBS, followed by 5 CV of 1×PBS and then 5 CV of storage buffer 
(1× PBS with 50% glycerol).  
 
ii) BicD2 affinity purification: 
Lysis: 4 pellets of 25 l culture (2 × 106 cells/ml) of Hela S3 cells were used for 
purification on one day, and for each pellet one BicD2 column of 5 ml CV was used. 
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The volume of each cell pellet was approximately 70 ml, and was resuspended in equal 
volume of dynein buffer supplemented with 1 mM DTT and protease inhibitors.  
Cell pellets were resuspended in dynein buffer: 30 mM HEPES pH 7.2, 50 mM KAc, 1 
mM EGTA, 5 mM MgAc, 0.5 mM ATP, 2 mM BME, supplemented with protease 
inhibitor and 10 µg/ml DNAse. The resuspended pellets were homogenised using 
polytron tissue dispenser (Blending cycle: 4x103 rpm, 1.5 mins; 2 minutes incubation on 
ice; 6.6 x103 rpm, 1.5 mins; 2 minutes incubation on ice; and last 6.6 x103 rpm,1.5 
mins). The homogenised extract from all the four pellets were cleared by centrifugation 
(at 38,000 rpm for 40 min at 4°C in a Ti45 rotor). The clarified lysate was then filtered 
through a 0.22 μm Steritop filter of 250 ml capacity (Millipore, Bedford, MA).  The 
filtered extract (approx. 400 ml) was equally divided in four parts each to loaded on 
separate BicD2 column. 
 
Loading the lysate onto BicD2 column: Approximately 100 ml filtered lysate was 
loaded at 0.5 CV/min onto a BicD2 column, which was preequilibrated with dynein 
buffer. Four columns were loaded in parallel. The column was washed with 5 CV of 
wash buffer (dynein buffer with 100 mM NaCl) at 1 CV/min flow rate. 
 
Salt gradient elution: The elution was done on Akta FPLC system (GE healthcare).  
Before elution the pumps were first washed with degassed water and the dynein buffer.  
Two BicD2 column were connected in series onto one AKTA system, and the dynein-
dynactin was eluted by applying linear NaCl gradient. The fractions enriched in 
dynactin were pooled, divided in 1 ml aliquots, flash frozen and stored at -80oC. 
 
Storage and re-equilibriating of BicD2 column: Column can be used repetitively if 
washed between runs with: 10 CV of 10× PBS, followed by 5 CV of 1×PBS and then 5 
CV of storage buffer (1× PBS with 50% glycerol).  
BicD2 affinity purification was done for three days using a total 300 l of HelaS3 cell 
culture. All the BicD2 column eluate were pooled and subject to anion exchange 
chromatography.  
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iii) Anion exchange chromatography – Mono Q 5/50 HR column 
BicD2 column eluate was exchanged into Mono Q equilibration buffer (35 mM Tris pH 
7.2, 5 mM MgSO4, with 0.5 mM ATP and 2 mM ßME) using 6 HiPrep 26/60 Desalting 
columns connected in series. The desalted protein was pooled and centrifuged (at 
70,000 rpm for 20 minutes using Ti70 rotor) and injected to an equilibrated Mono Q 
(washed with degassed water and in Mono Q equilibration buffer) column using a 150 
ml Superloop. After injection, the column was washed with 5 CV of Mono Q 
equilibration buffer, and the dynactin complex was eluted by applying a stepwise 
gradient of 1 M NaCl (1 M NaCl dissolved in Mono Q equilibration buffer), using the 
following programme: 
 
Table 5.4 Mono Q elution programme for purification of dynactin 
NaCl concentration 
(mM) 
Volume (ml) Flowrate 
(ml/min) 0 14.9 1.0 0-280 25.2 1.0 
280-320 Step  
320-340 46.8 0.5 
340-390 Step  
390-500 28.0 0.5 
500-1000 2.0 1.0 
1000 12.0 1.0 
1000-0 2.0 1.0 
 
The dynactin complex eluted at 390 mM NaCl in three fractions of 0.5 ml size. The 
fractions were pooled and exchanged to cryostorage buffer (30 mM HEPES, 50 mM 
KAc, 1 mM EGTA, 2 mM MgAc, 0.5 mM ATP, 2 mM BME, 10% glycerol, pH 7.2). 
After buffer exchange dynactin was centrifuged (at 70,000 rpm, at 4oC in TLA 110), 
flash frozen in 5 µl aliquots and stored in liquid nitrogen. 
For dynactin purification from pig brains, all the steps were the same except the 
following: 
1. Lysis: Two frozen pig brains were chopped into small pieces, the volume of 
lysis buffer added was two times the total volume of chopped brain pieces. The 
brain was thawed on ice and homogenized using a polytron dispenser following 
the same cycle as mentioned for HeLa S3 cell lysis. 
2. Clarifying the lysate: The homogenate after lysis was centrifuged twice, first: 
29000 g, 30 mins, in JLA 16.25 at 4oC; and second: 35000 rpm Ti45, 30 mins, 
4oC. The clarified lysate was not filtered. 
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3. Number of BicD2 columns: The lysate from two brains were loaded onto one 
BicD2 column, and the first round of purification was done in one day. The 
BicD2 column eluate were stored at 4oC and loaded onto MonoQ 5/50 HR the 
next day, following the same procedure as mentioned for purification from Hela 
S3 cells. 
 
5.7 Tubulin purification and polymerisation 
Tubulin was purified as described (Castoldi and Popov, 2003)and NHS- biotin (Pierce), 
NHS-Alexa 568 (Life technology) or NHS-Atto 647N (Sigma Aldrich) was covalently 
bound as decribed (Hyman, 1991).  
 
Preparation of GMPCPP-stabilized microtubules 
To prepare GMPCPP microtubule seeds, 0.8 μl labelled (Alexa 568 or Atto 647) tubulin 
(stock [150 µM]), 2 μl biotinylated Tubulin (150 µM), 2 µl of untagged tubulin (20 
mg/ml) were mixed, 5 µl of GMPCPP was added to the tubulin mix and BRB80 was 
added to make the total volume to 50 µl. This mixture was incubated for 1 hour at 37ºC 
for polymerization of microtubules. After polymerization, 450 μl warm BRB80 was 
added and centrifuge for 10 minutes at 17000 rpm in a tabletop centrifuge. The pelleted 
microtubule was washed with 100 µl of warm BRB80 and resuspend in 50 μl of warm 
BRB80. This method generated short GMPCPP seeds that were used in dynamic 
microtubule assays.  
 
For gliding and single molecule assays using stabilized microtubules (used in chapter 2 
and 3), the polymerized GMPCPP seeds were incubated at room temperature overnight 
to allow fusion and formation of long GMPCPP microtubules. Next day the 
microtubules were centrifuged again, washed twice with 100 µl of warm BRB80 and 
resuspended in 50 µl of warm BRB80. 
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5.8 Surface chemistry  
Functionalising glass with Tris-NTA and biotin-PEG  
Tris-NTA-PEG and biotin-PEG functionalised glass coverslips were prepared as 
previously described (Bieling et al., 2010), with the following modification for the 
biotin-PEG glass preparation: After silanisation, a mixture of 90% hydroxy-PEG-2000-
amine and 10% biotin- PEG-3000-amine (from Rapp Polymere) was coupled to the 
glass. Glass coverslips were stored at 4ºC.  
To assemble the flow cells, first the counter glass surface was passivated by streaking 
and drying PLL-PEG (poly (L-lysine)-PEG) and then washed extensively with distilled 
water. Four flow cells of approximately 10 μl volume each were built from one-fourth 
part of a functionalized coverslip and one PLL-PEG passivated counter glass, separated 
by two stripes of double sticky tape (Tesa). 
 
5.9 TIRF microscopy  
All microscopy data for results chapter 3 and 4 were acquired on a TILL Imic 4001 
TIRF microscope (http://www.till-photonics.com/Products/tirf.php) in 360 mode. Each 
fluorescent channel was split onto an individual cooled Evolve EMCCD camera 
(Photometrics), which allowed simultaneous imaging of a 488, 561 and 640 (based on 
excitation) channels. All microscopy data for results chapter 2 were acquired on an 
Olympus XI71 TIRF microscope. All TIRF imaging experiments in chapter 4 were 
performed at 30˚C. 
 
5.9.1 MT gliding assay  
(a) Microtubule gliding assay on Ni+2-Tris-NTA surface 
Tris-NTA-PEG functionalized glass coverslips were loaded with Ni+2 by incubating the 
surface with the following series of solutions: (1) 100 mM HCl for 2.5 min to clean the 
120 surface, (2) wash buffer (20 mM HEPES, 150 mM NaCl, pH 7.5) for 15 min, (3) 20 
mM NiCl2 in wash buffer for 5 min and (4) 200 mM imidazole in wash buffer for 5 min. 
The Ni+2-loaded slides were stored in wash buffer and used on the same day. Flow cells 
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were built from Ni-Tris-NTA-PEG functionalized coverslips and PLL-PEG passivated 
counter glass. The flow cells were first passivated by incubation with 50 μl 5% Pluronic 
F-127 in water for 5 minutes. The flow cells were then placed on an ice and washed 
with 50 μl immobilization buffer (motor storage buffer lacking glycerol). 20 μl His6-
motor diluted in immobilization buffer (the concentrations of motors are mentioned in 
the figures) was incubated for 30 minutes, followed by saturation of free Ni-Tris-NTA-
binding sites by incubation with 50 μl 10 μM His6-GFP (purified by Iris Lueke) diluted 
in immobilization buffer for 3 minutes. The non-bound proteins were washed off with 
50 μl immobilization buffer and 50 μl gliding assay buffer (GB: 10 mM PIPES, 35 mM 
KOAc, 2 mM MgSO4, 1 mM EGTA, 2 mM Mg-ATP, 2 mM β-mercaptoethanol, 20 
mM glucose, pH 7.0). The flow cells were warmed to room temperature and 50 μl of 
GB supplemented with oxygen scavengers (20 μg/ml catalase and 160 μg/ml glucose 
oxidase) and diluted Alexa 568-labeled GMPCPP microtubules (diluted in BRB80) 
were flown in the chamber. Microtubules were visualized at 25°C by time-lapse TIRF 
microscopy, using 100x objective. Microtubule transport was observed in 532 nm and 
time-lapsed images were acquired at 1s time intervals with 100 ms exposure times.  
 
(b) Kymograph analysis of gliding assays 
To determine the velocities of microtubule gliding from a time-lapse movie, the tracks 
of gliding microtubules were analyzed with the ‘Multiple Kymograph’ plug-in for 
ImageJ (J. Rietdorf and A. Seitz, EMBL Heidelberg). Velocities were determined from 
kymographs for gliding intervals of 2 minutes. About 100 microtubules were analyzed 
per condition. Microtubule gliding velocities were displayed in a histogram, and a 
Gaussian function was fitted to each histogram using Origin. The reported mean 
velocity is the center of the peak of the fitted Gaussian function and reported errors are 
standard error of the mean (s.e.m.). 
 
5.9.2 Single dynein motility on static MT 
For dynein motility experiments reported in Chapter 3, single GFP-labelled motors 
(artificially dimerised human and yeast dynein motors and human dynein complex) 
were imaged at low concentrations on immobilized fluorescently labelled GMPCPP 
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microtubules using TIRF microscopy (Bieling et al., 2010). The assay buffer was (AB): 
30 mM HEPES pH 7.2, 50 mM K-acetate, 2 mM MgSO4, 1 mM EGTA, 10 mM β- 
mercaptoethanol, 1 mM ATP previously used to study dynein motility in (Reck-
Peterson et al., 2006). Flow cells were built from biotin-PEG functionalized coverslips 
and PLL-PEG passivated counter glass. The flow chamber was passivated by incubation 
on an ice-cold metal block with 20 μl 5% Pluronic F-127 in water for 5 minutes, 
followed by washing with 50 μl of 50 μg/ml kappa-casein (Sigma) dissolved in assay 
buffer (AB). To enable microtubule immobilization, 50 μl of 50 μg/ml kappa-casein and 
50 μg/ml NeutrAvidin (Invitrogen) in AB were incubated for 5 minutes and the flow 
chamber was washed with 50 μl of kappa-casein containing AB and 50 μl of AB. The 
flow chamber was then allowed to warm up to room temperature, and 50 μl of diluted 
Alexa 568-labelled biotinylated GMPCPP microtubules in BRB80 were flown into the 
chamber and incubated for 5 minutes. Non-bound microtubules were washed out with 
50 μl BRB80 and finally, 50 μl of AB containing a 2 mM Mg-ATP, oxygen scavenger 
system (20 mM glucose, 20 μg/ml catalase and 160 μg/ml glucose oxidase) and mGFP-
motor (at concentration as indicated in the legends of the figures of experiments shown 
in results chapters) was flown into the chamber.  
Motors were immediately visualized by TIRF microscopy (100x objective and 1.6x 
optovar) and recorded by continuous streaming in the mGFP channel (488 nm 
excitation, 100 ms exposure) for 2 minutes, followed by generation of a static image of 
microtubules averaging a continuous stream of 10 images (532 nm excitation, 100 ms 
exposure time). The temperature was maintained at 25°C. 
 
5.9.3 DDB motility on static MT 
To study the processive motility of DDB (dynein-dynactin-BicD2400) on static 
microtubules (Chapter 3), the final assay buffer used was: 30 mM HEPES pH 7.2, 50 
mM K-acetate, 1 mM EGTA, 2 mM MgCl2, 1 mM ATP, 2 mM ßME, 20 mM Glucose, 
1.3 mg/ml Glucose oxidase (Serva) and 0.66 mg/ml Catalse (Sigma).  All the other 
steps were the same as single molecule dynein motility assay except the last step where 
instead of GFP dynein alone, a DDB mix (1 nM GFP Dynein, 2 nM purified human 
dynactin and 20 nM BicD2400 mixed and incubated at 4°C for 10 minutes) was added to 
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the final assay buffer. DDB motion was imaged via the GFP tagged dynein complex in 
488 nm channel by continuous streaming at 100 ms exposure for 2 minutes.  
 
5.9.4 Single molecule motility and end tracking on dynamic MT 
Reconstitution of plus end tracking and motion of dynein in the presence of 
combinations of EB1 and other dynein regulators was done in conventional flow cells. 
The experiments were based on (Telley et al., 2011). The flow cells were assembled, 
passivated and blocked as described in the previous single molecule assay (in section 
5.6.2). To the blocked flow cells, 50 µl of BRB80 with 50 µg/ml kappa-casein 
(BRB80k) was passed twice. Next, 50 µg/ml of NeutrAvidin (diluted in BRB80k) was 
flown and incubated for 5 minutes at 4°C. The unbound NeutrAvidin was washed from 
the flow chamber by flowing BRB80. After warming the flow cell to room temperature, 
Alexa 568 labelled biotinylated GMPCPP seeds diluted in BRB80 was passed through 
and incubated for 5 minutes in the flow cells. Depending on whether the final aim was 
to study DDB motility, dynein end tracking, or both in the same assay, the protein 
combinations and the subsequent steps were: 
 
(a) DDB motility assay on dynamic MT  
DDB mix was prepared [10 nM GFP dynein, 20 nM dynactin and 200 nM SNAP-
BicD2400  (for three colour imaging SNAPAlexa647BicD2400 was used instead of SNAP-
BicD2400)] and incubated for 10 minutes at 4°C. The flow cell was washed with BRB80 
and the final assay buffer (FB): 20 mM K-PIPES (pH 6.9), 50 mM KCl, 1 mM EGTA, 
2 mM MgCl2, 5 mM ßME, 1 mg/ml BSA (Sigma), 0.1 % Methylcellulose, 20 mM 
Glucose, 1.3 mg/ml Glucose oxidase (Serva) and 0.66 mg/ml Catalse (Sigma), 2 mM 
GTP and 2 mM ATP. 17.5 µM tubulin (with 10% Alexa 568 tubulin), and the DDB mix 
were added in the FB (the final volume was 30 µl). The FB mix with DDB and free 
tubulin was flown and the flow cell was sealed using vacuum grease (Beckman), and 
imaged by TIRF microscopy.  
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(b) GFP dynein plus end tracking assay 
The mixture of GFP dynein, dynactin and EB1 (the concentrations of each protein are 
mentioned in the figure captions of Chapter 4, typically 10-20 nM) were mixed and 
incubated for 5 minutes at 4°C. The dynein-dynactin-EB1 mix and 17.5 µM tubulin 
(10% Alexa 568) were added to the FB (same as above in (a)) 
 
(c) Simultaneously GFP dynein motion and end tracking assay 
The mixture of GFP dynein, dynactin, SNAP-BicD2400 and EB1 (DDB-EB) (the 
concentrations of each protein are mentioned in the figure captions of Chapter 4) were 
mixed and preincubated for 5 minutes at 4°C before adding to the final assay buffer. To 
the experiments with mCherry Lis1 (1 µM and 5 µM) was added to the DDB-EB mix 
and all the proteins were pre-incubated for 5 minutes at 4°C before adding to the flow 
cells.  This pre-incubated mix and 17.5 µM tubulin (10% Alexa 568) were added to the 
FB (same as above) 
 
(d) TIRF Imaging 
DDB motility and end tracking on dynamic microtubule was visualised by TIRF 
microscopy (100x objective) and recorded by timelapse in the mGFP channel at 488 nm 
excitation, and 100 ms exposure time. Images were recorded at 1 fps for 500 frames; 
simultaneously dynamic microtubule growth was recorded by timelapse in 561 channel 
by 532 nm excitation, 100 ms exposure time at 1 fps for 500 frames. The temperature 
was maintained at 30°C. Three colour imaging of the DDB motility on dynamic 
microtubule was visualized by simultaneous imaging of GFP dynein in 488 nm channel 
and Alexa 568 in 561 nm channel, and alternate imaging of SNAPAlexa647BicD2400 in 640 
nm channel. The exposure in all channels was 200 ms. Images were recorded at 1 fps 
for 500 frames. For three colour imaging of end tracking experiment simultaneous 
imaging of GFP dynein in 488 nm channel and Alexa 568 in 561 nm channel, and 
alternate imaging of SNAPAlexa647EB3 in 640 nm channel. The exposure in all channels 
was 200 ms at 1 fps for 500 frames. 
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5.10 Image analysis  
Image processing was performed using ImageJ (https://imagej.nih.gov/ij/) to generate 
kymographs and to merge image sequence from different channels. For multi-colour 
imaging, a calibration grid was used to correct for camera drifts. A Matlab based script 
for alignment, as described in (Maurer et al., 2014) was used merge image sequences 
based on the alignment of the grid images of different channels/camera. 
 
5.10.1 KymographDirect for dynein motion analysis 
A single kymograph of DDB motion shows complex trajectories, with moving, 
diffusing and static particles, often with crisscrossing paths which makes the manual 
analysis difficult. To this end, an ImageJ plugin KymographClear (Schneider et al., 
2012; Mangeol et al., 2016) allowed automated analysis of DDB. To analyse DDB 
motion on dynamic microtubules (results in Chapter 4), kymographs were generated 
from image sequences using KymographClear 2.0 ImageJ plugin developed by 
(Mangeol et al., 2016) (www.nat.vu.nl/~erwinp/downloads.html) (Figure 5.3).  First, a 
maximum intensity projection image was generated that was used to define tracks using 
segmented the line tool. After drawing a single track, the plugin generated kymograph 
by Fourier filtering (Mangeol et al., 2016), which produced three distinct kymographs 
showing forward moving, backward moving and pausing or static particles, which were 
present within a kymograph of a single trajectory.       
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Figure 5.3 Kymograph analysis of DDB motion.  
Analysis using KymographClear (to generate Fourier filtered kymographs) and KymographDirect (to 
trace,link and analyse trajectories in filtered kymographs) 
 
The kymographs are further analysed with the KymographDirect software developed by 
the same group (Mangeol et al., 2016). It allowed automated analysis of trajectories of 
moving and static kymograph. It is especially useful for obtaining accurate tracks while 
staying resilient to high noise content in images. The spurious trajectories were rejected 
manually, while the fragmented trajectory from a single track were linked manually 
using ‘link’ option of KymographDirect. Statistical analysis of the velocity and intensity 
along these trajectories are computed automatically (Mangeol et al., 2016). 
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5.10.2 Fluorescent intensity measurement at microtubule ends 
To quantify and compare the fluorescence intensity of dynein at plus end for various 
end-tracking experiments (in Chapter 4 of this thesis), GFP dynein intensities were 
measured from kymographs. The average intensity profiles were generated from 
dynamic microtubule assays data of GFP dynein at the growing microtubule end of 
labelled (Atto 647 and Alexa 568 labelled) dynamic microtubules (Figure 5.4): each 
kymograph was straightened and re-centred using the previously marked microtubule 
end positions. All the kymographs from one data set were aligned and averaged. The 
fluorescence intensities were then averaged for all time points at each position along the 
resulting kymographs to generate time-averaged spatial intensity profiles. For each 
assay conditions, the mean values of GFP dynein intensities from three experiments 
were plotted and the error bars show the standard deviation of each mean values. 
 
 
 
Figure 5.4 Fluorescent end intensity measurement 
The kymographs from each data set were straightened, aligned and averaged according to the premarked 
position of the ends to generate time averaged spatial GFP dynein intensity profiles. 
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5.10.3 Analysis of microtubule growth 
To determine the velocities of microtubule gliding from a time-lapse movie, the tracks 
of gliding microtubules were analyzed with the ‘Multiple Kymograph’ plug-in for 
ImageJ (J.Rietdorf and A. Seitz, EMBL Heidelberg). 50 microtubules were analyzed 
per condition. The mean growth velocity and standard error of the mean (s.e.m.) were 
plotted as column graph.  
 
5.11 Reproducibility  
All microscopy experiments were performed in triplicates (or more). For measurement 
of velocity and run length of processive DDB (dynein-dynactin-BicD2) over 200 
complexes were analysed per condition. For the GFP dynein end intensity at least 50 
MT plus ends were analysed per condition. All the test of significance reported are 
Student’s t-test. 
 
5.12 General computer software  
Image processing was performed using ImageJ and KymographDirect. Data analysis 
was performed using Microsoft Excel, Origin, and Matlab. These programs were also 
used to prepare graphs presented in the result figures.  Mass-spectrometry data were 
analysed using proteomic software Scaffold 
(http://www.proteomesoftware.com/products/scaffold/). Figures were prepared using 
Adobe Illustrator. The thesis was written in Microsoft word. Sequencing data were 
analysed using Ape. In silico PCR reaction, primer designing for infusion cloning were 
performed using SnapGene. 
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Chapter 6. Conclusion and Future Direction  
Besides transporting cargos to the microtubule minus ends, dynein often localises to the 
microtubule plus ends, and for both these tasks regulation of dynein is important 
(Cianfrocco et al., 2015; Kardon and Vale, 2009; Splinter et al., 2012). This thesis 
highlights how metazoan dynein regulators control the switch between dynein’s 
processive motion and its end tracking behaviour. While the non-processive dynein-
dynactin complex binds to EB1 at microtubule plus ends, addition of BicD2 activates 
processive dynein motion, and at high concentration reduces the dynein pool at plus 
ends starkly. This presents an in vitro evidence of biasing characteristics of BicD2, 
where BicD2 seems to bias dynein’s proceesive behaviour and a motion and reduces 
dynien’s plus end tracking.  This also explains why expression of adaptors (Num1—a 
cortical adaptor of yeast dynein and BicD2 fragments) depleted dynein from plus ends 
in yeast and mammalian cells (Lammers and Markus, 2015; Splinter et al., 2012). My 
findings also show that BicD2 and Lis1 compete to establish a shift between dynein 
motion and its microtubule localisation. When Lis1 and BicD2 are present in similar 
concentrations, Lis1 restores the dynein pool at plus ends, which was lost by the 
addition of BicD2. On the other hand, at levels lower than BicD2, Lis1 acts as an 
initiator of dynein motion (possibly by increasing the assembly of dynein-dynactin-
BicD2 processive complex on the microtubules). These findings explain the 
requirement of Lis1 in both plus end tracking (Coquelle et al., 2002; Splinter et al., 
2012), and processive dynein motion in cells (Splinter et al., 2012).  
Taken together, these results emphasize that dynactin, Lis1, and BicD2 are instrumental 
in guiding the key steps of dynein motion, namely, its microtubule recruitment, 
transport initiation and activation.  
The present work generates many avenues for further exploration of dynein regulation. 
First, how do Lis1 and BicD2 compete for binding to the dynein-dynactin complex? To 
understand this, a quantitative biochemical study of BicD2 and Lis1 interaction with the 
dynein-dynactin complex may be required. Second, do additional factors further 
regulate dynein during its plus end localisation and transport? For example, NudE could 
provide an additional layer of regulation by cooperating with Lis1 (Huang et al., 2012; 
Chapter 6. Conclusion and Future Direction 
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McKenney et al., 2010; Wang and Zheng, 2011) and competing with dynactin 
(McKenney et al., 2011) to bind to dynein. Further, CLIP170 could also provide 
additional regulation by interacting with dynactin and Lis1 at plus ends(Moughamian 
and Holzbaur, 2012; Moughamian et al., 2013). Finally, does the kinesin-dependent 
plus end transport of dynein also operate to further accumulate dynein pool at plus 
ends? In this regard reconstitution of plus end transport with the full-length BicD2 that 
can simultaneously interact with kinesin-1 and dynein (Grigoriev et al., 2007; Splinter 
et al., 2010) may provide important insights about the coordination of plus end and 
minus end dynein transport.   
It is intriguing how the myriads of dynein regulators act together to balance dynein 
activity spatio-temporally in cells. Dynein regulation in cells is mainly studied by 
overexpression or down regulation of dynein regulators, which may not represent the 
regulation observed at the physiological concentrations of these regulators. To this end, 
a cellular study of dynein regulation by fluorescently tagging dynein regulators, such as 
dynactin, Lis1 and BicD2 at their endogenous locus by CRISPR/Cas (Feng et al., 2013) 
would allow the dissection of physiological regulation of dynein in different stages of 
cell-cycle. 
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Appendix 
External contribution 
 
Chapter 1 
The recombinant human dynein complex and the artificially dimerised motor fragments 
were cloned by Martina Trokter. 
The pdyn3 construct was gifted by Dr. Andrew Carter (MRC LMB, Cambridge) 
Pauline Vercruysse cloned the yeast dynein motor fragment. 
 
 
Chapter 3 
Martina Trokter cloned mCherry Lis1 construct 
Johanna Roostalu provided the EB1 protein and provided experimental suggestions.  
Julian Gannon cloned the SNAP-EB3 construct. 
Nic Cade provide help with TIRF microscopy 
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